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Mapping the binding site of ligands to proteins using chemical exchange parameters by
NMR Spectroscopy
NMR spectroscopy, along with X-ray crystallography, have advanced to such an extent that
structure aided drug design is no longer just a concept on paper. With a myriad of techniques
in array, NMR spectroscopy is routinely used to screen ligands, locate binding site and design
site specific molecules. Almost all NMR experiments takes advantage of the fundamental be-
haviour of nuclei namely, the chemical exchange and relaxation phenomena, which can explain
the dynamic nature of macromolecules (proteins) and their complexes (protein + ligand) in so-
lution. Classical Bloch-McConnell equations are commonly used to study mechanisms ranging
from simple to complex interactions in a quantitative way. We adopted the same approach, to
understand the relationship between NMR derived kinetic parameters and the underlying inter-
action mechanism for protein-ligand systems. Using hBclXL (protein) and BH3I-1 (ligand) as
a standard system for the fast exchange regime (weak binding case), we have shown that the
rate of change within a population from the free to bound state, can differentiate the binding
site residues from the non binding site residues. The analysis is carried out by an in house
written ‘c’ program ‘Auto-FACE’, which uses a genetic algorithm to optimize kinetic (Keq) and
spectral parameters (ω) after performing appropriate mechanism dependent free ligand correc-
tions. Further, adopting the transition probability approach, a more comprehensive dynamic line
shape analysis was automated and implemented to study different chemical exchange regimes
without invoking any approximations. MCL-1 (protein) and NOXA-B (peptide), a typical slow
x
exchange system (tight binding case), was analysed and showed that there are regime dependent
limitations on using kinetic parameters to interpret binding processes.
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1.1 Has structural biology delivered what it has promised?
By the start of 20th century scientists all over the world were complacent with the theory based
on classical physics and thought the conquest for explanation of every physical phenomenon
was over, till new experiments like black body radiation and the photoelectric effect emerged.
The failure and inadequacy of classic physics to explain the above experiments later lead to the
birth of quantum mechanics. Aa analogous scenario can be seen for the quest of targeted drug
design[1], where solving the structure of proteins was held as the final obstacle for designing
drugs precisely[2]. Concomitant advances in technology also made it possible to achieve
this goal by getting the structure, but when this idea was put to test, the outcomes were not
promising[3, 4, 5, 6]. This resulted partly due to a lack of consideration for the dynamic
aspects of protein-ligand interaction.
A protein by itself is a very intrensically dynamic molecule. When a ligand is added to
this system, the nature by which both interact with each other varies greatly from commonly
encountered electrostatic, van der Waals, and dipole-dipole interactions to specialised phi stack-
ing processes[7, 8]. The bound ligand molecule, after a period of time called ‘residence
time’[9, 10], gets out of the binding pocket as a free molecule. The rate at which this happens
defines the affinity of interaction. With this global picture of ligand binding to protein on one
1
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side, when we consider the local rearrangement of the residues within the binding pocket, the
degree of dynamic complexity increases exponentially.
1.2 Protein-ligand interaction and drug discovery
The three important stages of drug discovery, namely: lead generation, lead optimization and
pre-clinical development require detailed structural information of the target protein and the
ligand at atomic resolution[8, 11, 12, 13]. Structural details not only enhance the understanding
of the mechanism of interaction but also help us to improve a weakly interacting molecule in to
a highly specific therapeutic molecule. In the first stage of drug design, a large library of ligands
are screened against the target protein and molecules showing characteristic selectivity towards
the target protein are chosen for further study into the nature of the interaction[14]. The
identification of the binding pocket for these molecules is the subsequent stage which greatly
assists in shaping these molecules to lead molecules. Once the scaffold of the lead structure has
been decided upon, a diverse set of molecules are then synthesized to imporve on the selectivity
and affinity towards the target protein[15, 16].
The promising candidates are taken to the next stage to characterize their toxicity and
bioavailability in animal models. If the molecules show poor metabolism or cell toxicity[17,
18], the structural information obtained during the preliminary stages is used to redesign the
ligand to enhance enzymatic degradation in the liver, kidney and lungs. The finally refined
molecule is formulated as a therapeutic drug. In all three stages of drug design, a set of simple,
effective, robust and sensitive techniques is required to perform quantitative assays on protein-
ligand interactions.
2
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1.3 Techniques to investigate protein-ligand interaction
Many of the techniques available for studying protein-ligand interactions can be broadly classi-
fied into global techniques ( which details the interaction at a global level) and high resolution
techniques which gives information at the atomic level.
ITC (Isothermal calorimetry)[19], fluorescence polarization and surface plasmon resonance
techniques, each belonging to the former class, are sensitive techniques that measure the glob-
ally averaged parameters[20]. Delineation of stoichiometry and the mechanism of interaction
is straight forward and accurate using these techniques. During the preliminary stages, these
techniques are best suited for screening the right candidate ligands from non-specifically in-
teracting molecules, and later on, quantitatively comparing the affinity and specificity of the
selected ligand molecules.
Techniques like NMR spectroscopy and X-ray crystallography are complex in principle but
yield information at the atomic level of resolution[21]. Mapping of the interaction site also
referred to as “Epitope mapping”[22], is possible with both of these techniques. Unfortunately,
both techniques suffer from stringent criteria for sample preperation like high concentration of
protein and ligand (>1 mM) in very pure form (> 98%). Hence a good expression system for the
target protein of interest is quintessential to perform structural studies using these techniques.
1.4 NMR based methods for protein-ligand interaction
X-ray crystallography, unlike NMR, has no limitation on molecular weight for structure deter-
mination of macromolecules. Most of the drugs successfully synthesised based on structure
directed rational drug design is owed to a high quality structure determined by X-ray technique.
On the other hand, NMR offers a variety of experiments that would complement X-ray studies,
to study the dynamics of a protein as well as its interaction with other molecules[4, 23, 24, 25].
3
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The dynamics in NMR are attributed two phenomenon namely, chemical exchange and relax-
ation. By studying these phenomenon, we can explain the structural changes that happen within
the molecule. Processes like tautomerism, ‘H’ exchange, ring flipping and isotropic methyl ro-
tation are examples of chemical exchange phenomenon, whereas molecular tumbling, internal
correlation and even chemical exchange contribute to the relaxation of nuclei’s energy. While
studying protein-ligand interactions the effects of both chemical exchange and relaxation are
clearly evident in the spectra of both protein and ligand. Hence, the tools developed to study
such systems focus on protein or ligand or both. In differentiating the protein from its interact-
ing partner either the difference in molecular weight or differential isotope labelling stratergy is
adopted. Some of the commonly used NMR experiments to study protein-ligand interactions
are:
1. Exchange NOE experiment
2. Saturation transfer difference experiment
3. Waterlogsy experiment
4. HSQC perturbation experiment
5. Relaxation dispersion experiment
6. Isotope edited or filtered experiments
7. CPMG (Carr-Purcell-Meiboom-Gill sequence) experiments
1.4.1 Exchange NOESY experiment
Exchange NOE relies on the transfer of magnetization from protein to ligand while it interacts
with protein and that it retains the same even after it dissociates from the binding site[26, 27].
The ligand’s ability to retain its bound conformation, after its residence time at the binding
4
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pocket, helps us to measure the NOEs of the ligand’s bound conformation. The principle behind
exchange NOE is illustrated in figure. 1.1.
L + P L P L + P
Free protein and ligand Bound complex Dissociated complex
L : No NOE for unbound ligand conformation
L : Strong NOE for bound ligand conformation
Fig. 1.1: Illustration of transfer NOESY experiment: When ligand interacts with the protein, the confor-
mation of both protein and ligand changes, resulting in a variation of NOE patterns between the free and
bound forms. The structure of the complex can be calculated using the intramolecular and intermolecular
NOEs obtained from this experiment.
The exchange NOE can be either from intramolecular or intermolecular nuclei. Intramolec-
ular NOE are easily observed and usually dominate the spectrum, whereas the most informative
intermolecular NOEs are seen only through scrupulous optimization of the mixing time in the
experiment[28, 29]. As the NOE pattern of the bound form would be different from that of the
free form of the ligand, the conformation of the protein-ligand complex can be calculated using
exchange NOE as the experimental constrain.
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1.4.2 Saturation transfer difference experiment
STD also relies on transfer of magnetization from protein to ligand[22, 30]. This experiment is
more suitable for small to medium sized ligands (∼ 1 KDa) that are weakly interacting with large
target proteins (>30 KDa). At the outset of the experiment, the protein is saturated with a series
of on-resonance pulses near the chemical shift of the methyl region. Through the process called
“spin diffusion”(magnetization leakage through bonds and space), which is predominantly seen
for large molecules, the protein gets saturated. If any ligand interacts with this saturated pro-
tein, the signal would be transferred from the protein to the ligand during its residence time.
Subsequently, the transverse magnetization of protein is eliminated through the spin lock step
employed in the experiment[9, 30]. Since proteins are large, they relax much faster during spin
lock leaving only the ligand signal to be detected. If the ligand does not interact with protein,
there would not be any transfer of signal before the spin lock step, hence no signal would result.
On the other hand, if the ligand binds strongly to the protein, it becomes a part of the complex
and its signal would be completely annihilated during the spin lock step. Hence neither the
very strong binder nor the very weak binders can be studied through this technique. The signal
transfer at each stage of the experiment is illustrated in figure. 1.2 for three different cases of
interaction.
1.4.3 waterLOGSY
Water-Ligand Observed via Gradient Spectroscopy shares the same principle as that of the STD
NMR experiment except the transfer of magnetization takes place through water molecules
bound to ligand[31, 32, 33]. Initially, the solvent water molecules are saturated with selec-
tively designed pulses. By spin diffusion and cross relaxation, the bound water saturates the
protein at the region of interaction. If a ligand interacts with the protein, the saturated binding
pocket residues transfer the signal to the interacting ligand. Following this, the water signal is
6










Spin saturation Spin lock Signal
Strong affinity
(KD: < 10−9 M)
Intermediate affinity
(KD: 10−7 − 10−3 M)
Weak affinity
(KD: > 10−3 M)
Fig. 1.2: Illustration of STD experiment: The transfer of signal from protein to ligand is modulated by the
spin lock step. If the affinity is strong, the signal is annihilated. If it is moderate, the signal will be retained.
For weaker interactions, the signal would not be transferred at all. The circle and box represent protein
and ligand respectively. Hatched structures represent magnetized molecules in contrast to non-magnetised
empty structures.
selectively inverted through another selective pulse. This labels the binding ligand with a neg-
ative signal resulting from a cross relaxation effect between bound water and the ligand. Thus,
when a mixture of binders and non binders are added to the target protein, the binders signal
will be inverted with respect to the non binders. WaterLOSGY is one of the most sensitive
technique available for studying protein-ligand interaction.
1.4.4 HSQC perturbation experiments
Proteins can be selectively labeled with 15N or 13C nuclei while being expressed in a suitable
bacterial expression system. The protons directly attached to 15N or 13C through single bond
can be selectively studied using HSQC (Hetero nuclear single quantum coherence) experiments.
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H (dimension) H (dimension)
N15 HSQC spectrum of
protein alone
N15 HSQC spectrum of
protein titrated with ligand
Fig. 1.3: Illustration of HSQC perturbation experiment: The peaks present in a HSQC spectrum comes
from protons directly attached to 15N or 13C heteronuclei, depending on 15N or 13C HSQC experiment
respectively. Initially, the spectrum is recorded in the absence (left) and presence of ligand (right). The
interaction of ligand would result in perturbation of chemical shifts, which are represented as arrows in the
right side figure.
The 15N HSQC spectrum of a protein will contain all the amide and amine protons present in
the peptide linkages and side chains. The same experiment, when recorded with the addition of
ligand, the chemical shifts of the amide protons will shift due to conformational changes caused
by ligand interactions[34]. The perturbed amide protons are directly related to the ligand
interaction and hence, used to map the binding site (figure. 1.3). Like 15N HSQC, 13C HSQC
can also be used to map the binding site. Since there are different types of carbons present
within proteins such as Cα, Cβ, Cγ , Cδ and Cη, the spectrum can be analyzed for any type of
functional group. Usually the spectral region corresponding to methyl groups are analysed, in
spite of it being highly crowded or overlapped.
8
CHAPTER 1. Introduction NMR based methods for protein-ligand interaction
1.4.5 Isotope edited or filtered experiments
The protein or ligand samples can be isotopically enriched with 15N or 13C, so that the protons
attached to these isotopes can be selectively manipulated or edited through ‘Isotope editing’
experiments. Whereas the naturally present 14N , 12C isotopes in non-enriched samples can be
eliminated or filtered using ‘Isotope filtering’ experiments[35, 36]. For mapping the binding
site using edited or filtered experiments, the protein can be isotopically labelled, while retaining
the ligand unlabelled. The experiment is designed such that only the signal of protons attached
to 15N are edited for the protein, while the signal from 12C protons of unlabeled ligand are
filtered retaining only the 14N attached protons. When an NOE spectrum is recorded with
selectively retained 15N protons from protein and 14N protons from ligand only the binding site
residues will show up resulting in direct mapping of the binding site. The principal difference



















Fig. 1.4: Illustration of isotope edited or filtered experiment: As one of the interacting partner is labelled
and the other unlabelled, the exchange NOE is possible only through the residues at the interaction site.
N15 protons are selectively edited for proteins and C12 protons are selectively filtered for ligand. Hence, in
contrast to ordinary NOE, only signal originating from N14 protons of ligand is transferred to N15 protons
of protein. Thus, enabling the direct mapping of binding site residues.
9
CHAPTER 1. Introduction Proteins involved in cancer: an excellent target system for drug design
1.4.6 CPMG experiments
CPMG experiments are the derivatives of the well known classical ‘spin-echo’ experiments[37,
38, 39]. When the effective relaxation rates (Reff ) are measured as a function of varying
CPMG frequencies (i.e. the rate at which spin-echo pulses are employed in the experiment),
the resulting profile of decaying Reff encapsulates the accurate details of relaxation caused ex-
clusively by chemical exchange[40]. Assuming appropriate kinetic mechanism in Richard-
Craver’s model, the experimental profile can be fitted to obtain four important parameters
namely, kex, ∆ω, P (population) and R0[41, 42]. The kex obtained through CPMG experi-
ments are accurate and has been used sucessfully to quantitate binding process and to locate the
binding site residues[43]. Additionally, the determination of ∆ω, has a significant application
on identifying the chemical shift of invisible higher energy states. Once, the chemical shift of
invisible state is determined from visible state, the structure of the invisible state protein can be
calculated. (The problem is to determine ω2 from ∆ω = ∣ω1∣ − ∣ ± ω2∣, ω1 is known as it cor-
responds to the chemical shift of visible state, now the sign of ω2 is obtained through HMQC
based experiment[37]. With ω1 and the sign of ω2 in hand ω2 is determined directly from
∆ω[40, 44]. ))
1.5 Proteins involved in cancer: an excellent target system for
drug design
The survival or death of the cell is regulated by an intricate mechanism called “apoptosis”,
which involves many upstream and downstream proteases in the process[45, 46, 47]. The
proteases are specifically termed as “caspases” (cysteine aspartic acid proteases) because of the
presence of cysteine and aspartic acid in their catalytic triad[48]. Currently, there are two
independent mechanisms by which caspases are activated (figure. 1.5).
10
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1. The intrinsic pathway (mitochondria based)
2. The extrinsic pathway (death receptor based)
















































































































Fig. 1.5: Mechanism of apoptosis
1.5.1 Mechanism of Apoptosis
In the intrinsic pathway, stress factors like cytokine deprivation trigger the release of cytochrome-
c from mitochondria[49]. The released cytochrome-c is sequestered by a factor called Apaf-1
(Apoptosis activation factor) present in the cytoplasm. This factor oligomerises to form a com-
plex named as ‘apoptosome’. The apoptosome has peptidase activity, which can cleave inactive
procaspase 9 to its active form caspase 9. Upon activation, caspase 9 catalyses the cleavage of
caspase 3, which irreversibly leads the cell to its death, by activating further caspases down-
stream. The members of the Bcl-2 family are a set of proteins which regulate (stimulate/inhibit)
the activity of the apoptosome and caspases at various levels[50]. Bcl-2 family proteins are
broadly classified into pro-survival and pro-apoptotic proteins based on their function and se-
quence similarity (figure. 1.6).
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Fig. 1.6: Classification of BCL-2 family proteins
The pro-survival or anti-apoptotic proteins include Bcl-2, hBclXL, Bcl-w, Mcl-1 and A1.
They all exhibit four conserved domains namely the BH (Bcl2 homology) domain 1 to 4
(figure. 1.7). All the members possess a hydrophobic C-terminal tail in addition to a char-
acteristic hydrophobic groove spanned by the BH1, BH2 and BH3 domains (figure. 1.9)[51, 52,
53, 54]. These proteins directly interact with the apoptosome and counteract its proteolytic
activity, consequently checking the progression of apoptosis.
The pro-apoptotic proteins are classified into two types, namely, ‘Bax like’ proteins and
‘BH3 only proteins’. The ‘Bax like’ proteins contain three BH domains namely, BH1 through
BH3, but lack the BH4 domain additionally present in the pro-survival proteins. Bax, Bak and
Bok are members of this group. The second class of proteins, the ‘BH3 only proteins’ are
the minimalists, containing only the BH3 domain[55]. Bim, Bid, Bmf, Noxa and Puma are
members of this group. Both of these classes induce apoptosis either directly or indirectly,
e.g. Bax and Bak can directly interact with the mitochondrial membrane and cause release of
cytochrome-c , which in turn activates the apoptosome. Whereas, ‘BH3 only proteins’ indirectly
induce apoptosis by binding to the hydrophobic groove of pro-survival proteins and prevents
their normal anti-apoptotic activity.
12
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Fig. 1.7: The three BH domains namely: BH1, BH2, BH3 are highlighted in different colors. The BH4
domain present near the N-terminal of Bcl-2 proteins is not included in the sequences. The BH domains are













Fig. 1.8: The sequence alignment of the BH3 domain of different pro-apoptotic proteins, here the highly
conserved residues leucine and aspartate are highlighted.
Unlike the intrinsic mechanism, the extrinsic mechanism involves by default, the membrane
bound receptors called ‘FAS mediated death domain’ receptors. When a cell gets damaged,
FAS ligands are released. These ligands, in turn bind to FADD receptors and cause direct
activation of the procaspase 8 enzyme. The active caspase 8 in turn cleaves procaspase 3 and
commits the cell towards apoptosis.
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(a) hBclXLwith Bim peptide (b) mMCL-1 with NOXA-B peptide
(c) hBclXL’s hyrophobic groove residues (d) mMCL-1’s hyrophobic groove residues
Fig. 1.9: Figure (a, b): shows the complexed form of hBclXLwith bim peptide and mMCL-1 with NOXA-B
peptide. Figure (c, d): The hydrophobic groove residues of hBclXLand mMCL-1 that are involved in the
interaction with pro-apoptotic proteins are highlighted.
1.5.2 Structure aided drug design for cancer treatment
Targeting cancer related proteins through structure aided drug design is one of the hotly pursued
research area in vogue. Some of the important targets whose activation/inhibition have shown
promising results in cancer therapy are [56, 57]:
14
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1. The TRAIL agonist (TNF related apoptosis inducing ligand receptors)
2. Inhibitors of Bcl-2 family proteins [57, 58]
3. Inhibitors of IAP proteins (inhibitors of apoptosis)
4. Inhibitors of MDM2
TRAIL are natural receptors for TNF (tissue necrosis factor), which are released when cells
are damaged. TRAIL gets activated upon binding to TNF and recruits FADD (FAS associ-
ated death domain) receptors in subsequent steps. FADD directly activates caspase 8 as ex-
plained above. Agonists (stimulator) of TRAIL receptors can trigger the death of cancer cells
effectively[56, 57].
Bcl-2 proteins prevent apoptosis by stabilizing the mitochondrial membrane from releasing
cytochrome-c. In chronic lymphocytic leukemia, Bcl-2 proteins are overexpressed, preventing
the cell from responding to normal apoptotic regulation[59, 60, 61]. Drugs like gossypol
inhibit Bcl-2 oligomerization by binding to their hydrophobic groove, which sensitizes the cells
to apoptosis.
SMACs (Second mitochondria derived activators of caspase), are natural apoptotic proteins
released from mitochondria. IAP’s (Inhibitors of apoptosis) bind to SMACs and prevent apop-
tosis. Inhibitors of IAP’s potentially activate apoptosis mediated by SMACs.
The transcriptional activator protein, p53 induces cell arrest and apoptosis. In many can-
cer types, p53 is either mutated or inactivated along with negative regulation of overexpressed
MDM2, which accelerates p53 degradation. Inhibitors of MDM2 would limit the turnover rate
of p53 and positively commit the cancer cell towards apoptosis.
15
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1.6 Using NMR to understand the dynamic protein-ligand
interactions
Chemical exchange and relaxation are two important phenomena which add the dynamical
sense to the NMR experiment[62, 63]. In a protein-ligand interaction system, the structural dy-
namics are inherently a part of it. Both the chemical exchange and relaxation phenomenon are
affected in a characteristic way for such dynamic systems. Chemical exchange by definition, is
the switching of environments by a nucleus occuring at a particular rate, whereas, relaxation is
the process by which the nucleus gets back to its equilibrium state by losing its energy. Both
these phenomena can be studied in a classical way (in contrast to a quantum mechanical ap-
proach) through Bloch-McConnell equations. In this work, we have tried to get deeper insights
into how chemical exchange affects the NMR derived parameters like chemical shift, Keq etc.




2.1 Protein sample preparation
The DNA sequence of human hBclXL starting from residues M1 to M218, with a flexible loop
region R45 to A84 being deleted, was subcloned into a modified pET-32a (Novagen) vector
which lacks the S-tag and thioredoxin genes. The plasmid was transformed into the E. coli
BL21(DE3) strain and the His tagged protein was expressed at 37○C. IPTG was added to a
final concentration of 0.4 µM when the optical density of cells reached 0.6 (measured at 600
nm). The culture was allowed to grow at the same temperature for another 8 hours before
the cells were harvested. The bacterial culture was centrifuged at 6000 rpm and the pellet
was collected and sonicated. The suspension was clarified by centrifugation at 18000 rpm at
4○C. The supernatant was taken and passed through a Ni–NTA agarose column (Qiagen) and
washed thoroughly with wash buffer (20 mM Tris, pH 7.9 containing 30 mM imidazole and
0.5M sodium chloride) before being eluted with wash buffer containing 0.5 M imidazole. The
eluent was dialyzed against 50 mM Tris pH 7.9 overnight at 4○C. The dialysed protein was
concentrated to 4 mL. Thrombin and calcium chloride were added to a final concentrations of 3
units/mg of protein and 3 mM, respectively, to cleave the His tag. After digestion, hBclXL was
purified further on a superdex 75 prep grade column (GE Healthcare) using 50 mM Tris pH 7.9
buffer containing 0.5 M sodium chloride and with a flow rate of 1ml/min. Finally, the purified
fractions containing hBclXL were pooled together and dialyzed against 20 mM phosphate buffer
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at pH 7.0. NMR samples were prepared by concentrating the above sample to 0.6 mM using
a centrifugal concentrator with a membrane cutoff of 5 kDa (Viva-spin 20, Sartorius). For
preparation of 15N labeled sample, the protein was expressed in M9 minimal media containing
15N ammonium chloride as the sole nitrogen source, while LB medium was used for preparing
the unlabeled samples.
The sequence starting from E153 to G308 of mMCL-1 was subcloned into PGEX-4T1 and
transfected into the E. coli BL21 (DE3) cells. Large scale expression was carried out at 37
°C, by induction with IPTG to a concentration of 0.5 µM, when the cells reached 0.8 OD. The
cells were harvested after 8 hours and centrifuged at 6891 x g. The pellets were sonicated in
phosphate buffer saline (PBS, pH 7.0), and clarified by centrifugation at 26,581 × g at 4 °C.
The fusion protein was seperated from cell debris using a GST sepharose column; after several
washes with PBS (> 5 column volumes), the GST tagged mMCL-1 was eluted with 10 mM of
reduced glutathione. The eluent was concentrated to 1 mL for enzymatic cleavage of the GST
tag using 5 units/mg of bovine serum thrombin and 3mM calcium chloride. Highly purified
mMCL-1 were obtained by further purification with FPLC (Superdex 75 prep grade column,
rate: 1 ml/min, 50 mM Tris pH 7.9 in 0.5M NaCl). The fractions eluted about the 65th ml were
pooled and exchanged with 20mM phosphate buffer containing 0.01% sodium azide, using a
centrifugal concentrator, for NMR studies.
2.2 ITC titration
4 mL of 25 µM of hBclXL and 0.8 mL of 1 mM BH3I-1 were prepared in 20 mM phosphate
buffer pH 7.0 containing 2.5% DMSO and degassed under vacuum for 20 minutes. In the
reference cell, 20 mM phosphate buffer at pH 7.0 containing 2.5% DMSO was used. 0.3 mL
of BH3I-1 was titrated into 1.2 mL of hBclXL at 25○C over 28 injections of 10µL each. A
blank experiment was performed by titrating BH3I-1 into the sample cell containing 1.2 mL of
18
CHAPTER 2. Material and Methods 15N HSQC titration
buffer alone. Buffer alone was titrated into a protein sample to confirm that the heat of protein
dilution was negligible. The isothermal chromatogram was integrated and analyzed using the
commercial software Origin 5.0.
2.3 15N HSQC titration
20 µL of 40 mM of BH3I-1 in D6 DMSO was titrated serially into 550 µL of 0.58 mM 15N
labeled hBclXL. The 15N HSQC spectra were recorded at 25○C for different protein to ligand
ratios of 1:0.23, 1:0.46, 1:0.69, 1:0.92, 1:1.15, 1:1.14, 1:1.61, 1:1.82, 1:2.07 and 1:2.30. The
data were acquired with a resolution of 2048 and 128 points in the direct and indirect dimensions
and eight scans were accumulated for each titration. The obtained spectra were processed with
NMRPipe 9 [64, 65]. Solvent and polynomial baseline corrections were done with an auto
flag. The data were padded with zeros to twice its size in both dimensions to increase the
digital resolution of the peaks. Apodization using a phase shifted sine bell function (θ = 90○)
of order one was performed for the acquired dimension and of order two for the indirection
dimension. Linear prediction was done for indirect dimension before apodization. The phase
corrected spectrum was assigned using Sparky 3.114 and resonance lists were generated for all
spectra[66].
0.22 mM of mMCL-1 was titrated with the NOXA-B peptide in the following protein
to peptide ratios of 1:0, 1:0.09, 1:0.182, 1:0.455, 1:0.727, 1:0.909, 1: 1.818, 1:2.727. The
15N HSQC spectra were processed using NMRpipe 9 and assigned using Sparky. The back-
bone assignment of free and NOXA-B complexed mMCL-1 were carried out as explained in
[52].
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2.4 J-Surface mapping
J-Surface mapping requires 15N HSQC titration data and PDB coordinates of the protein. The
“jsurf” module written by McCoy and G. Moyna was integrated with an in house written pro-
gram to automate and analyze all the serially titrated data. The coordinates of all the amide
protons were sorted from the PDB file, and the chemical shift perturbation, ∆CS = CSprotein
- CSprotein+ligand, for the corresponding protons were determined from the sparky assignment
files. The electron density map was calculated from the magnitude and direction (±) of pertur-
bation values. The region showing higher ‘j’ density was identified to be the binding site for
ligand.
2.5 Molecular docking
Automated docking was performed using Autodocksuite-4.0.1[67]. The coordinates of com-
plexed (1BXL and 2YXJ) and free (1LXL) hBclXL were obtained from the protein database[68].
Structures of (R, S) BH3I-1 were generated in SYBYL-7.0 and atom types were assigned with
considerations for stereo-specificity. Prior to docking, protons and charges were added to pro-
tein and ligand structures using MGLTools-1.5.2[69]. For BH3I-1, the number of rotatable
bonds were set to 4 and docking was performed with Lamarckian-Genetic algorithm. The vari-
able resolution was set at 250 (population size) and energy evaluation was performed for 25×105
conformations per run. 100 such runs (or generations) were performed. Ligand conformations
within 1 RMSD difference were clustered together. Unlike blind docking, where the docking




Analysing fast chemical exchange systems
3.1 Abstract
The role of NMR spectroscopy in studying protein-ligand interactions is becoming more and
more important with the advent of innumerable experiments varying from simple to complex
designs. The dynamic details that NMR offers can be studied even with a simple experiment
like HSQC. The concomitant improvements in hardware and method development have dramat-
ically reduced the time required for acquiring the spectrum, e.g. ‘SOFAST-HMQC’, requires
less than 25 seconds to achieve the same sensitivity as conventional HSQC that required 3.5
minutes[70, 71, 72]. NMR experiments can be used not only for screening ligand library but
also for mapping its binding site. When a ligand is added to a protein at increasing concen-
trations, the chemical shifts of the nuclei of the protein get perturbed due to interactions with
the ligand. However, residues can also be perturbed by non-specific changes other than ligand
interaction, e.g. allosteric effects and local rearrangement. Considering this, we have developed
a robust method which makes use of three parameters namely: initial rate of perturbation, bind-
ing affinity and magnitude of perturbation, to identify and map the binding site residues. Using
this approach, we have studied the interaction of a complex protein-ligand system, hBclXL and
BH3I-1, through HSQC perturbation experiments and obtained new insights into its binding
mechanism. The geometrically averaged equilibrium constant (3.0 × 104) calculated for the
residues present at the identified binding site is consistent with the values obtained by other
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techniques like isothermal calorimetry and fluorescence polarization assays (12.8 × 104). Ad-
jacent to the primary site, an additional binding site was identified which had an affinity that
was 3.8 times weaker than the former one. Further NMR based model fitting for individual
residues suggest a single site model for residues present at these binding sites and a two site
model for residues present between these sites. This implies that chemical shift perturbation
can represent the local binding event much more accurately than the global binding event. This
methodology is automated and implemented in our program Auto-FACE (Auto-FAst Chemical
Exchange analyzer).
3.2 Introduction
Basic research on protein-ligand and protein-protein interaction has contributed a lot to the
success of structure-aided drug design and development[11]. A myriad of techniques are avail-
able to study such interactions, among which NMR spectroscopy has been unique in giving
dynamic details at atomic resolution[8, 73, 74]. The chemical shift, a fundamental property
of each nucleus, gets perturbed when an adjacent nucleus comes in close proximity to it.
Such perturbation can be explained with the help of phenomena like “chemical exchange” and
“relaxation”[75, 76]. Extensive theories are available to explain chemical exchange and re-
laxation, based on which, many of the complicated NMR experiments have been successfully
established[10, 77, 23]. Chemical exchange by definition is the switching of nuclei from one
environment to another. For instance, the addition of a ligand or a change in either pH or tem-
perature could result in chemical exchange[75]. On the other hand, relaxation is a process by
which the excited nucleus return to its ground/equilibrium state[78, 79]. The inherent nature of
the nucleus and its surroundings influence the relaxation process.
Both chemical exchange and relaxation modulate the basic line shape characteristics of
NMR like the offset or, analogously, Larmor frequency, the line width at half maximum, and
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the phase and intensity of peak[75, 80]. For a two state system, where nucleus A is chemically






Assume λ1 and λ2 represents the Larmor frequency of A and B, MA and MB are the respective
magnetization. By default, MA will give rise to a peak at λ1, but because of chemical exchange
with B, it will also give rise to a peak at λ2. Conversely, MB will give rise a peak at λ2
and because of chemical exchange with A, it will also give rise to a peak at λ1 [80]. The
analytical expression forMA andMB can be obtained by solving the classical Bloch-McConnell
equations[81, 82, 83].
To study the chemically exchanging species individually, an easier approach would be to
look at the components at λ1 and λ2 rather than signals MA and MB[80, 82, 84]. Both MA and
MB contribute to the component peaks at λ1 and λ2. Addition of the λ1 components from MA
and MB and the λ2 components from MA and MB would give a spectrum that can be easily
analyzed as λ1 and λ2 peaks, since these components correlate directly with population A and
B (Figure 3.1 ). Moreover, the rate of chemical exchange is also important as it influences
all the above mentioned peak characteristics significantly. Based on the rate (k), the chemical
exchange phenomenon can be classified into fast, intermediate and slow exchange regimes.
By definition, fast exchange requires ∣λ1 − λ2∣ < k, whereas for slow exchange, ∣λ1 − λ2∣ >
k. In intermediate exchange, the difference in Larmor frequency of the exchanging species
is equal to the exchange rate i.e. ∣λ1 − λ2∣ = k[85]. Experimentally, fast exchange systems
will show a single peak with the components of A and B appearing at a population weighted
frequency λavg, where λavg is in between λ1 and λ2. In intermediate exchange, a single peak
will appear as seen with fast exchange, but the phases of the contributing components A and
B are highly distorted and gives rise to a very broad peak. Sometimes, it may even disappear
amidst noise peaks due to a poor signal to noise ratio. In slow exchange, two individual peaks
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appear at λ1 and λ2 corresponding to the componentsA andB, the areas of which are population
weighted. To summarize, chemical shift, phase and peak intensity are population weighted for
fast, intermediate and slow exchange systems, respectively (Figure 3.2)[85].
A B
Fig. 3.1: (left) Component signals of population A and B. (right) Structural comparison of BH3I-1 and
its analogue BH3I-2. (A) MA and MB both contributes to the component peaks at λ1 and λ2 which is
directly correlated with its respective population A and B. (B) & (C) Structural comparison of BH3I-1 and
its analogue BH3I-2.
The fast exchange protein-ligand systems show a characteristic ‘peak walking’ pattern in
spectra on gradual addition of ligand. This variation in chemical shift due to increasing ligand
concentrations can be explained analytically by a linear combination of population weighted
individual chemical shifts[86, 87]. For example, in a two state system comprised of free [P ]
and bound protein [PL], the averaged chemical shift δ is given as,
δ = δ[P ]f[P ] + δ[PL]f[PL]
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where f[P ] = [P ][PT ] , the mole fraction of [P ], f[PL] = [PL][PT ] , the mole fraction of [PL] and [PT ] =
[P ] + [PL], the total protein concentration. δ[sub] refers to the chemical shift corresponding
to the subscripted free or bound form. Weakly interacting ligands with complex mechanisms
can be studied in detail by making such fast exchange approximations[87]. Here we show that
detailed analysis of chemical shift perturbations for a complex fast exchange systems enable
us to obtain parameters like the rate of change of perturbation, binding equilibrium constant
and magnitude of chemical shift perturbation, which can be used to distinguish the binding site
residues from the bulk of residues.
A B C
Fig. 3.2: Simulation of fast, intermediate and slow exchange regimes for two site chemical exchange using
Mexico 3.1[88]. The offset (ω1, ω2) are set at ± 300Hz for site A and B. The T2 relaxation rates are 1Hz
each. Assuming forward and reverse rates to be same, the chemical exchange rates are set at 2400 sec−1,
1200 sec−1 and 100 sec−1, for fast, intermediate and slow exchange systems, respectively. In all cases, the
population of A:B is fixed at 1:1. (◽◽◽ : Component of site A, ◾◾◾ : Component of site B, ÐÐ : Sum of both
components (A+B)).
3.3 Results and discussion
3.3.1 Mechanisms of protein-ligand interaction
The mechanism of interaction can be as simple as a single site binding or a complex sequential
binding. In any case, if the ligand interacts weakly with the protein exhibiting shorter residence
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time, fast exchange approximations can be made and explicit analytical expressions can be
derived for δ relating [L][86, 87, 89]. In the fast exchange approximation, two assumptions are
empirically made,
1. The overall chemical shift is the sum of population weighted individual chemical shifts
2. All the exchanging species are in equilibrium
Mechanisms explaining different physical situations are considered for example:
1. Single site binding (3.1)
2. Sequential two site binding (3.2)
3. Simultaneous ‘n’ site binding (3.3)
4. Single site binding with an allosteric contribution (3.4)
which are illustrated as,
[P ] + [L] k+1GGGGGGBF GGGGGG
k−1
[PL1] (3.1)
[P ] + [L] k+1GGGGGGBF GGGGGG
k−1
[PL1] + [L] k+2GGGGGGBF GGGGGG
k−2
[PL2] (3.2)
[P ] + n[L] k+1GGGGGGBF GGGGGG
k−1
[PLn] (3.3)





where [P ] and [L] denotes free protein and ligand species. [PL1], [PL2] and [PLn] are the
ligand bound protein forms. Assuming the fast exchange approximation, the expressions for δ
can be written as
δ = δ[P ]f[P ] + δ[PL1]f[PL1] [model (3.1)]
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δ = δ[P ]f[P ] + δ[PL1]f[PL1] + δ[PL2]f[PL2] [model (3.2)]
δ = δ[P ]f[P ] + δ[PLn]f[PLn] [model (3.3)]
δ = δ[P ]f[P ] + δ[PL1]f[PL1] + δ[PL2]f[PL2] [model (3.4)]
where δ represents the averaged or overall chemical shift and f[sub] and δ[sub] are the mole
fraction and chemical shifts for the subscripted species, respectively. Assuming equilibrium,
mole fraction can be explicitly written in terms of [L] as follows,
δ =
δ[P ] + δ[PL]KA[L]
1 +KA[L] [model (3.1)] (3.5)
δ =
δ[P ] + δ[PL1]KA[L] + δ[PL2]KAKB[L]2
1 +KA[L] +KAKB[L]2 [model (3.2)] (3.6)
δ =
δ[P ] + δ[PL1]KA[L]n
1 +KA[L]n [model (3.3)] (3.7)
δ =
δ[P ] + δ[PL1]KA[L] + δ[PL2]KAKB[L]
1 +KA[L] +KAKB[L] [model (3.4)] (3.8)
3.3.2 Correction for free ligand concentration
In the above equations the free ligand concentration [L] appears rather than total ligand concen-
tration [LT ]. The determination of [L] from [LT ] is mechanism dependent and can be obtained
by making use of ligand mass balance. The polynomials used for correction are
KA[L]2 + (1 + [PT ]KA −KA[LT ])[L] − [LT ] = 0 [model (3.1)] (3.9)
KAKB[L]3 + (KA + [PT ]KAKB − [LT ]KAKB)[L]2
+(1 + [PT ]KA − [LT ]KA)[L] − [LT ] = 0 [model (3.2)] (3.10)
K1[L]n+1 + ([PT ] − [LT ]K1)[L]n + [L] − [LT ] = 0 [model (3.3)] (3.11)
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Physically, only one value is possible for [L], so the choice of right root is judiciously made by
considering that
1. The root must be real and positive.
2. It’s value cannot exceed [LT ].
If many roots meet the above criteria, then the one that is closest to [LT ] is chosen.
3.3.3 Automation using genetic algorithm
A common feature that is seen from the simple model fitting to the complex structure calculation
is the optimization of the desired parameters using experimental data as constraints. For any
such problem, proper definition of the target or the objective function is critical for steering
the optimization towards the global minimum. Different protocols are available to perform
optimization, e.g. simulated annealing (SA), genetic algorithm (GA), simplex and Levenberg
Marquardt algorithm (LVM), etc. To accelerate the convergence step for finding solutions,
sometimes the gradient calculations are incorporated along with objective function, e.g. LVM.
Instead, methods like SA and GA rely on random sampling of the entire parameter space to
obtain the best combination. Here, GA has been implemented to optimize and determine the
parameters for different fast chemical exchange models[90].
For a serial titration experiment with n different ligand concentrations, n chemical shift
values will be obtained for each residue. The objective function for fitting to an appropriate










Here δ[n′]exp and δ[n′]calc are the experimental and calculated chemical shift values. For the
calculation of δ[n′]calc, we can consider the model (3.6), having five parameters namely δ[P ],
δ[PL1], δ[PL2], KA and KB to be optimized. Initially, random values for each parameter within
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the specified lower and upper bound values will be generated. These limits are automatically
specified from the experimental data. With the generated parameters, the free ligand concen-
tration [L] will be calculated from [LT ] using the equation (3.10). From the calculated [L]
and parameters, δ[n′]calc will be evaluated for each titrated ligand concentration. The objective
function is finally calculated from δ[n′]exp and δ[n′]calc. This process is iterated several times
till a convergent minimum value is obtained for each objective function. Successful acheive-
ment of the global minimum depends primarily on setting the correct lower and upper limits
for the parameters. The genetic algorithm based parameters like cross-over rate, mutation rate
and number of generation also influence the quality of the fitting. The Jack-knife algorithm has
been incorporated for the determination of standard errors for the parameters. The whole anal-
ysis is automated through an in-house written C program ‘Auto-FACE’ (Auto-FAst Chemical
Exchange analyzer). ‘Auto-FACE’ is highly interactive, user friendly and portable to different
platforms.
3.3.4 Mapping the binding site of BH3I-1 onto hBclXL
hBclXL is a key member of the anti-apoptotic Bcl2 family of proteins[46, 50]. It is up regu-
lated in different types of cancers and confers to cancer cells resistance to normal apoptotic
signals[91]. Targeting and inhibiting hBclXL is one of the therapeutic strategies in treating re-
calcitrant cancer[92]. BH3I-1 on the other hand is a small ligand (400.31 Da) which has been
identified to bind to the BH3 binding groove of hBclXL (Figure 3.1). Similar to BH3I-1, the
structural analogue BH3I-2 can also displace the Bak peptide from the hydrophobic groove
of hBclXL (Figure 3.1). The results of the fluorescence polarization assays (FPA) suggest that
the weakly interacting BH3I-1 (7.8 µM KDa) can displace the strongly bound Bak peptide (16
residues; Kd = 0.34 µM). The mechanism could be more complex than a simple competi-
tive displacement[93]. Previous studies carried out with BH3I-2 (an analogue of BH3I-1) and
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hBclXL generated a differential pattern in HSQC perturbation for a single substitution of Br
group to H[94]. Residues like N136, G138, I140, A142, F146, G147, G148 and R91 were
differentially perturbed and were identified to be the binding site residues[94]. In the current
analysis we have used hBclXL and BH3I-1 as a standard system to validate our automated anal-
ysis program.
3.3.4.1 Results of ITC titration
To confirm the interaction of BH3I-1 with hBclXL, ITC titration was performed. The isother-
mal binding curve fit well to the three sites sequential binding model with good statistics for
the parameters (Figure 3.3 and Table 3.1). A closer look at the equilibrium constants for all
three processes revealed that the last event could merely be a non-specific allosteric change
rather than an actual binding process. This is evident from its lower Keq value (103) and much
higher ∆S value (34 cals). A recent comparative work on the thermodynamics of the protein-
ligand interaction shows that ∆H is more correlated with the binding process than ∆S[95, 19].
Considering the possibility that the third process might not be significant, the global interaction
mechanism could be primarily dictated by the first two enthalpy dominant processes.
Table 3.1: Thermodynamic parameters obtained from the ITC experiment by fitting the data to sequential
three site binding model.
Three sequential binding model χ2 = 559.097
KEquilibrium ∆ H (cals) ∆ S (cals/deg(K))
4.869 × 105 ± 4.412 × 104 −6.81 × 103 ± 0.71 × 102 3.182
9.322 × 104 ± 6.632 × 103 −2.387 × 103 ± 0.88 × 102 14.73
1.584 × 103 ± 1.117 × 102 −1.464 × 104 ± 0.72 × 103 34.46
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Fig. 3.3: Isothermal binding curve for BH3I-1 titrated into hBclXL. (◻) : Blank experiment where 1 mM of
BH3I-1was titrated into 20 mM phosphate buffer. (∎) : 1mM of BH3I-1 was titrated into 25 µM hBclXL. In
all buffer solutions, concentration of DMSO was adjusted to 2.5 %.
3.3.4.2 NMR titration
BH3I-1 was serially titrated into hBclXL at increasing ligand concentrations and 15N HSQC spectra
were recorded. On overlaying the spectra, more than half the peaks exhibited ‘peak walk-
ing’ pattern characteristic of fast exchange (Figure 3.4). Compared to the rest of the residues,
stronger perturbations were observed for residues like F146, G148, G94 and G196 (Figure 3.4).
Structurally, F146 and G148 are 10 A˚ away from the latter residues G94 and G196. We pro-
ceeded with the detailed analysis on chemical shift by fitting the data against binding models
like the single site, two site sequential, multiple sites simultaneous and single site with allosteric
contribution models to interpret the binding mechanism. Almost all residues fit well to the sin-
gle site model and a few remaining ones were represented better with the two site sequential
model. The F-test and Akaike’s criteria were used to choose the simplest best model statistically
(Figure 3.5 and Table 3.2)[42, 96, 97, 98].
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A B
Fig. 3.4: Generalized 15N HSQC perturbation observed for all residues. (A) Overlaid perturbation spectra
for all residues and (B) Selected residues with significant “peak walking” chemical shift perturbation. The
Reddish-orange contour represents the spectrum of protein alone and blue contour represents the spectrum
of protein with the maximum titrated ligand concentration. F146, G148 reaches saturation at the protein to
ligand ratio of 1:1, whereas saturation could not be reached for G94.
3.3.4.3 Binding site analysis using NMR based parameters
The mapping of binding site was carried out using the following parameters,
i) Binding equilibrium constant
ii) Initial rate of perturbation
iii) Magnitude of the perturbation
Among these parameters, the last two can be either calculated from model equations and
fitted parameters or obtained directly from experimental data. For further analysis, a detailed
consideration on the fundamental differences between H and N chemical shift is required for
correct interpretation of the data. The chemical shifts calculated from protein structures and
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Fig. 3.5: Comparison of single and double site binding models for different residues. Comparison of two
different models for residues present at the binding site (A - H) and the non binding site (I - L). ● ● ● :
Experimental data, ⋅ ⋅ ⋅ ⋅ : Single site model, ÐÐ : Two site sequential model.
quantum mechanical treatments by semi-empirical and ab initio methods shows that several
factors contribute to the chemical shift value in an additive manner[99, 100]. ForH resonances,
the primary contributions come from ring-current effects, magnetic-anisotropic effects, electric
field effects, and the length and orientation of hydrogen bonds[101]. However, N resonances
are strongly influenced by the side chain conformation of the preceding residue (i − 1). Hence,
backbone torsion angles (ψ − 1, φ) and side chain chi angle (χ − 1) are the major contributing
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components[102]. In a perturbation setting like protein-ligand interactions, H resonances can
be interpreted unambiguously as ring-current effects of the ligand itself contribute directly to
H shift. But for N shifts, complication arises due to the convoluted contributions from ligand
and structural changes. Our present analysis considers both H and N shifts with an underlying
assumption that allosteric structural changes are minimized at lower ligand concentrations and
the major contributions come from the direct interaction of the ligand with protein. Taking the
first derivative of the equation (3.5) with respect to [L] relates dδ
dt
∝ 1[L]2 , which implies that at
lower ligand concentration the rate of change of δ will be larger. But at higher concentrations
of [L], the slope decreases parabolically. Thus the more sensitive information content is en-
capsulated in the initial perturbation data rather than at later stages of the titration. The initial
perturbation data at lower ligand concentrations also circumvents non-specific interactions and
allosteric structural changes that are more likely to occur at higher ligand concentrations. For
example, a recently proposed mechanism for cyclic AMP receptor protein (CRP) and cAMP
association suggests that two independent binding processes preceds a subsequent three step
conformational changes. In this case, if more emphasis is given to the data content at initial
stages, where binding process dominates, the effect of non-specific perturbations caused by
conformational changes can be eliminated[103].
A 3D graphical plot of the listed parameters greatly assists in identifying the binding site
residues (Figure 3.6). The initial perturbation rate, as explained above, is more sensitive in
distinguishing the critical binding site residues from the bulk residues (3.6). On the other hand,
the binding equilibrium constant and magnitude of perturbation are also correlated with the
binding process but influenced by non-specific interactions as well. Hence, these parameters
are used in later stages only to refine the residues selected based on initial rate of perturbation.
Appropriate threshold levels are set for each parameter statistically or manually. For initial
rate of perturbation, ∣0.01∣ and ∣0.5∣ ppm/mM corresponding to 1.0 σ value was set for H and
N resonances, respectively. Only perturbations greater than ∣0.01∣ and ∣0.1∣ ppm for H and
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N resonances were considered. The threshold for equilibrium constants was based on median
analysis. The values falling within 0.15 and 0.7 quartiles were selected for both H and N
resonances.
Residues like G94, E96, Q111, L112, V126, E129, F143, F146, G147, G148, V192 and
G196 from theH plot and residues like L90, L99, Q111 and I114 from theN plot were mapped
onto the structure of hBclXL (Figure 3.7A & Table 3.2). Two distinct regions that are adjacent
to each other but separated by a minimum distance of 10 A˚ were identified. The first site (A)
is located at the edge of the extended hydrophobic BH3 groove near the ‘C’ terminal region.
Residues like G94, E96, L99, V192 and G196 that constitute this site are part of the BH3
domain. The second site (B) is located in the middle of the highly conserved but less exposed
hydrophobic groove. Residues like Q111, L112, V126, E129, F143, F146, G147 and G148 that
spans the BH3 binding groove are proximally distributed within the BH1 and BH2 domains. As
mentioned above, the perturbation at the saturation limit may or may not be directly related to
the binding process. This is evident from residues like F27 and K157 that are not at the binding
site, as confirmed by the slope values of 0.035 and 0.014 ppm/mM, but have high perturbation
values of 0.211 and 0.346 ppm. This implies that mapping binding site using perturbation alone
could be misleading in complex protein-ligand interactions.
3.3.4.4 J surface mapping
To localize the binding site, we have also performed J-surface mapping using the same perturba-
tion data. In principle, the ring current effect of the aromatic ligand causes strong perturbation
of amide protons present adjacent to it[105, 106]. The electron density map calculated for the
ligand from the sign and magnitude of perturbation could locate the position of the ligand at
the binding pocket. Since BH3I-1 contains an aromatic ring, the J surface map could be cal-
culated at all titrated ligand concentrations (Figure 3.7B & C). At lower ligand concentrations,
the J-surface map is localized near the central helix α5, where residues like L90, G94, D95,
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Fig. 3.6: ‘3D’ plot to differentiate the binding site residues from bulk residues. (A) and (B) are plots for H
and N resonances, with no threshold set for slope and magnitude of perturbation. (C) and (D) are plots for
H and N resonances, with threshold set at σ = 1.00 which corresponds to 0.01 and 0.5 ppm/mM for slope
values of H and N residues and to ∣0.01∣ and ∣0.1∣ ppm for magnitude of perturbation of H and N residues.
For both plots, equilibrium constants falling within the 0.15 to 0.7 percentile were used.
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A B C
Fig. 3.7: Mapping of the unique residues identified from ‘3D’ plot onto the structure of hBclXL and com-
parison with J-surface mapping. (A) Two distinct regions are shown which are colored differently (red,
yellow); (B) & (C) are the J-surface mapping of BH3I-1 at lower (P:L::1:0.229) and higher (P:L::1:0.918)
ligand concentrations, respectively. The initial map appears diffused covering G94, G196, G148 residues
but slowly converges near F143 and F146 as the concentration of ligand increases. J-surface map were
calculated using JSURF program considering perturbations > ∣0.05∣ ppm. Other parameters like ms (stan-
dard deviation for data spread), np (number of random points to fill the sphere)and ar (an offset in A˚ added
to radius of sphere) were set at 3, 2000 and 1, respectively. All the figures were made using the software
Chimera[104].
F97 and V141 are located (site A). But at higher ligand concentrations, the J-surface mapping
converged to a region where residues like F143, F146 and G147 are located (site B). The latter
site is completely buried and inaccessible to the ligand in the closed conformation of hBclXL.
3.3.4.5 Binding mechanism
In order to get a quantitative sense of the interaction, the equilibrium constants for the two
distinctly mapped regions were geometrically averaged from the individual residues flanking
these sites. The equilibrium constants averaged to 2.970 ×104 and 0.775 ×104 for sites B and
A, respectively. The affinity of site B is 3.8 times stronger than site A. When the results of
J surface mapping are also considered, we propose that site A is a weaker site where BH3I-1
makes its first contact with the protein. Because of its dynamical nature[107], this interaction
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Table 3.2: Parameters determined by fitting of chemical shifts to equations (3.6) & (3.7) for hBclXL and
BH3I-1 system. Most of the residues fitted well to single site binding model with a few residues fitted better
to two site sequential model. Initial perturbation rate (slope), binding affinity and magnitude of pertur-
bation (∣△CS∣Calc) are listed below. For model selection F-test and Akaike’s criteria based analysis were
performed. Fcritical value for F-test is chosen based on the degree of freedom (the number of parameters
present in the model, i.e. 3 and 5 for single and two site, respectively) and level of significance (α = 0.05).
The FStandard or Fcritical was found to be 5.049. Fcalc > Fcritical suggests simpler model (i.e. single site)
cannot explain the experimental data satisfactorily. The null hypothesis is rejected and the complex two
site binding model is chosen. Akaike’s information criteria was calculated for both models, the lower AIC
value indicates the better model.
Residue. δ0 δmax Equilibrium Slope ∣△CS∣Calc F - statistics Akaike’s criteria
no. (ppm) (ppm) constant (KA or KB) (ppm/mM) (ppm) (Standard: 5.049) (AIC)
Binding site residues
‘H’ resonances
G148 8.958 9.165 3.1290 ± 0.2716 × 104 0.240 0.207 1 (1.311) 1 (-11.89 / -9.32)
F146 9.204 9.383 24.1123 ± 4.0886 × 104 0.224 0.180 1 (1.871) 1 (-12.25 / -9.27)
L112 7.495 7.306 1.7979 ± 0.1785 × 104 0.204 0.189 1 (2.716) 1 (-17.05 / -12.69)
G94 9.129 8.828 0.2056 ± 0.0097 × 104 0.195 0.300 1 (2.329) 1 (-12.28 / -8.78)
V192 7.870 7.658 0.4296 ± 0.0344 × 104 0.180 0.211 1 (0.539) 1 (-5.86 / -3.66)
Q111 7.723 7.542 0.6775 ± 0.0577 × 104 0.163 0.181 1 (3.304) 1 (-10.24 / -8.98)
E96 8.293 8.444 4.4784 ± 1.6428 × 104 0.162 0.151 2 (118.500) 2 (-8.12 / -8.22)
V126 7.172 7.074 10.5379 ± 2.6728 × 104 0.120 0.098 1 (0.239) 1 (-10.46 / -8.53)
F143 8.111 8.217 2.1494 ± 0.3548 × 104 0.119 0.106 1 (2.837) 1 (-13.67 / -8.81)
G147 8.086 8.817 3.1401 ± 0.6247 × 104 0.116 0.101 1 (2.429) 1 (-16.71 / -13.05)
E129 7.345 7.250 2.7540 ± 0.5867 × 104 0.108 0.095 1 (1.039) 1 (-12.55 / -10.85)
G196 7.998 7.895 0.9103 ± 0.1505 × 104 0.102 0.103 1 (0.536) 1 (-10.96 / -9.13)
‘N’ resonances
I114 122.620 124.677 0.3363 ± 0.0024 × 104 1.98 2.06 1 (0.303) 1 (-18.59 / -14.89)
Q111 118.894 117.731 3.2953 ± 0.0555 × 104 1.3 1.16 1 (2.554) 1 (-10.24 / -8.98)
L99 117.247 7.49 1107.3352 ± 673.3090 × 104
7.833 0.0110 ± 0.0028 × 104 1.11 1.08 2 (143.581) 2 (-7.99 / -9.88)
L90 120.121 119.009 0.3163 ± 0.0043 × 104 0.81 1.11 1 (1.447) 1 (-11.17 / -10.78)
F144 120.848 121.301 10.9532 ± 0.6110 × 104 0.53 0.45 1 (0.781) 1 (-13.91 / -12.79)
Non binding site residues
‘H’ resonances
M170 8.990 8.931 487.0460 ± 21.5370 × 104
8.914 0.7460 ± 0.9310 × 104 0.088 0.080 2 ( 927.198) 2 (-14.63 / -18.37)
K16 8.327 8.405 0.6013 ± 0.1229 × 104 0.069 0.078 1 (0.827) 1 (-13.15 / -10.83)
N136 6.327 6.376 0.3091 ± 0.0909 × 104 0.039 0.050 1 (0.618) 1 (-15.28 / -13.04)
T41 8.249 8.344 0.0549 ± 0.0102 × 104 0.031 0.096 1 (2.771) 1 (-14.60 / -10.02)
S2 8.374 8.394 3.4162 ± 0.0358 × 104 0.024 0.021 1 (1.463) 1 (-12.94 / -11.33)
V86 7.528 7.502 0.3209 ± 0.1847 × 104 0.020 0.025 1 (2.766) 1 (-15.02 / -10.47)
subsequently lead to the exposure of the hydrophobic groove for the more critical interaction
of BH3I-1 with site B to occur. The consistency in the site predicted by our chemical shift
analysis, J surface mapping and the stoichiometry suggested by ITC all points to the possibility
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of a complex sequential binding mechanism. This also explains why a small ligand with weak
affinity like BH3I-1 can displace the Bak peptide that binds strongly to hBclXL[93]. Further,
more mutation studies with L130A, R139A and R100E suggest that these residues are crucial
for BH3I-1 interaction and notably, the first two residues are present at site B and the last one
near site A[93].
NMR model fitting suggests the single site model to be appropriate and good enough for
residues present at site A and site B, this is in contrast to the two site model as suggested by
the global interaction mechanism. The inconsistency can be explained by making a valid as-
sumption that chemical shifts are highly dependent on local environment and their perturbation
also reflects the same. In this regard, the residues located at site A and B fit well to single site
models, but the residues in between these sites, influenced by both the binding processes, would
require a two site binding model to explain their behavior. From our analysis, one such residue
G148, was found to be represented best with two site model (Figure 3.5). Thus NMR titration
data, unlike ITC titration data, pictures the local binding mechanism much more accurately than
the global binding mechanism.
3.3.4.6 Docking results
Docking performed with perturbation differences between BH3I-1 and BH3I-2 as constraints
resulted in the models shown in Figure 3.8A[94]. In our case, initial blind docking resulted in a
majority of the ligand conformations (80%) docked to site B. The BH3I-1 oriented itself with
its phenyl ring buried deeply inside the hydrophobic pocket of site B, making close contacts
with L130, F146 and A149 (Figure 3.8B). As blind docking resulted only limited conformations
of BH3I-1 at site A, a constrained docking was performed for site A, with the docking grid
confined to NMR perturbed residues at this site. In this docked conformation, the phenyl ring
of BH3I-1 is partially exposed in a shallow groove, which suggest a weaker interaction for this
site.
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A B
Fig. 3.8: Comparison of the previous and current docked models of BH3I-1 on to hBclXL. (A) and (B)
compares the published and current docked models of BH3I-1 on to hBclXL respectively. In the published
model, the stoichiometry was constrained to a single site, so the ligand preferred the site in between the two
adjacent pockets. In the current model, two BH3I-1 molecules bind adjacent to each other with distinctive
affinities. The key residues that interact with BH3I-1 within 5 A˚ unit are highlighted. In Figure (B), site A
is highlighted in yellow color and the site B in red color.
3.A Appendix:Automated data analysis
The resonance list file generated by ‘Sparky’ is used as an input to our in house written ‘C’
program (Auto-FACE). The software and its manual is freely available upon request. Curve
fitting for different models were performed for individual residues and the parameters with its
standard error were written in separate files. Using binding affinity, initial rate of perturbation
and magnitude of perturbation, binding site analysis was performed and ‘3D’ plots were gen-
erated for H and N resonances. The quality of the plot depends on the threshold set for each
of these parameters. Except the affinity constant, which is obtained only by model fitting, the
other parameters can either be calculated or obtained from experimental data.
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The number of binding constants depends on the models used, e.g. equation (3.10) has two
equilibrium constants, KA and KB . For analysis, either an individual binding constant (KA
or KB) or a geometrically averaged value (KA and KB) can be used. If the data are poor,
the model fitting may fail for some residues and result in excessively high or low values for
the equilibrium constant. Such artifacts can be eliminated by median analysis. The user can
specify the upper and lower quartile values for residue selection.
The initial rate of perturbation is calculated using the following expression,
S = mean(S1, S2, . . . , Sn) where Sn′ = ∣ δn′+1 − δn′[Ln′+1] − [Ln′]∣ (3.13)
Ln′ and Ln′+1 are the n′th and its subsequent higher ligand concentration; δn′ and δn′+1 are
the corresponding chemical shift values. The average of the rates of first few data points well
below the half saturation limit was used for binding site analysis. Statistically, the slope values
exhibited a normal distribution. In this regard, most of the bulk residues would have their
slope value centered near the mean (x) and the binding site residues having large slopes would
be present outside ± 1 or 2 σ (standard deviation). The residues were selected depending on
stringency of σ and the threshold.
The magnitude of perturbation is the absolute difference between the chemical shift of free
protein and ligand complexed protein. The user can define threshold in terms of ppm for ‘H’
and ‘N’ resonances. Final ‘3D’ plots would be generated using the software ‘gnuplot’ [108].
3.B Appendix:Deriving complex models
The derivation of the two site sequential binding is explained below.
[P ] + [L] k+1GGGGGGBF GGGGGG
k−1
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In this mechanism the protein exists as [P ], [PL1] and [PL2] in solution. The averaged chem-
ical shift is
δ = δ[P ]f[P ] + δ[PL1]f[PL1] + δ[PL2]f[PL2] (3.14)
δ and f refers to the chemical shift and mole fraction of the appropriately subscripted molecular
species i.e. free or bound form. The mole fractions f[P ], f[PL1] and f[PL2] can be expressed
in terms of ligand concentration assuming equilibrium for the system. But here a more general
approach of framing differential equations for each exchanging species is adopted.
d[P ]
dt
= −k+1[P ][L] + k−1[PL1] (3.15)
d[PL1]
dt
= +k+1[P ][L] − k−1[PL1] + k−2[PL2] − k+2[PL1][L] (3.16)
d[PL2]
dt
= +k+2[PL1][L] − k−2[PL2] (3.17)
The terms on R.H.S are constituted by multiplying the rate constant with its corresponding
reactant. The sign indicates whether a particular rate increases (+) or decreases (-) the concen-
tration of the considered species. At equilibrium, the above equations are equated to zero as
concentration of [P ], [PL1] and [PL2] will not vary with respect to time.
d[P ]
dt
= 0 gives k+1[P ][L] = k−1[PL1]
d[PL1]
dt
= 0 gives (k−1 + k+2[L])[PL1] = k+1[P ][L] + k−2[PL2]
d[PL2]
dt
= 0 gives k−2[PL2] = k+2[PL1][L]
In fact, the above relationships can also be obtained from the conventional equilibrium assump-
tion. But when time dependent analysis is required, e.g non-steady state systems, the above
simultaneous differential equations have to be solved analytically to obtain the mole fractions.
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The resulting expression for chemical shift would then depend not only on ligand concentration
but also on time[109, 110, 111, 112]. On rearranging the above equations, [PL1] and [PL2]
can be expressed in terms of [P ] as follows,
[PL1] =KA[P ][L] (3.18)







. Since total protein [PT ] is equal to the sum of free as well as
bound forms,
[PT ] = [P ] + [PL1] + [PL2] (3.20)
Substituting (3.18), (3.19) into (3.20) gives expressions for [P ], [PL1] and [PL2] in terms of
[PT ] and [L].
[P ] = [PT ]
1 +KA[L] +KAKB[L]2 (3.21)
[PL1] = [PT ]KA[L]
1 +KA[L] +KAKB[L]2 (3.22)
[PL2] = [PT ]KAKB[L]2
1 +KA[L] +KAKB[L]2 (3.23)
Substituting [P ], [PL1] and [PL2] back into (3.14) yields,
δ =
δ[P ] + δ[PL1]KA[L] + δ[PL2]KAKB[L]2
1 +KA[L] +KAKB[L]2 (3.24)
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3.C Appendix:Calculating [L] from [LT ]
The total ligand concentration [LT ] is equal to the sum of free and complexed forms of ligand.
For two site sequential binding, the ligand can exist in three states,
LT = [L] + [PL1] + [PL2]
[PL1] and [PL2] can be written in terms of [L] as explained by equations (3.22) and (3.23).
Therefore,
LT = [L] +PT [ KA[L]
1 +KA +KAKB[L]2 ] + PT [
KAKB[L]2
1 +KA +KAKB[L]2 ]
On rearranging, the polynomial equation that has to be solved is obtained.
KAKB[L]3 + (KA +PTKAKB −LTKAKB)[L]2
+ (1 +PTKA −LTKA)[L] −LT = 0
44
CHAPTER IV
Analysing all chemical exchange systems
4.1 Abstract
NMR based protein-ligand titration data (15N HSQC ) contains rich information on chemical
exchange and relaxation behaviour of individual amide protons corresponding to each residue.
Dynamic line shape analysis (DLNS) can be carried out for the given titration data to get de-
tailed insights on the nature and mechanism of the interactions quantitatively. Using Bloch-
McConnel equations, the simulation of DLNS is straightforward, and further when combined
with an optimization technique like the genetic algorithm, the required relaxation and kinetic
parameters can be determined. Though there are spectral differences seen among fast, interme-
diate and slow exchange regimes, the recently proposed transition probability based approach
for chemical exchange unifies all the exchange regimes under one roof and generalises the
spectral interpretation. Adopting this approach, we have implemented the mechanism based
correction for free ligand concentration (L) and population determination that precludes the ne-
cessity for additional experiments for carrying out line shape analysis. Results from analyzing
a fast exchange system i.e. hBCL-xl (protein) and BH3I-1 (ligand), and a slow exchange sys-
tem i.e. mMCL-1 (protein) and NOXA-B (peptide), shows that though there exists a positive
correlation between the spectral derived kinetic parameters and binding event, the degree of
correlation decreases gradually from fast to slow exchange. Particularly, for tight binding slow
exchange cases, the NMR determined equilibrium constant differs by an order of 105 from the
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measurements of SPR (surface plasmon resonance) and FPA (Fluorescence polarisation assay)
techniques. The reason for this discrepancy is attributed to two events namely: the binding event
(initial step) and the structural rearrangement (subsequent rate limiting step) being unsynchro-
nised as seen with an induced fit mechanism. As the NMR measurement averages out both of
these processes over time, the information on the slower step i.e. structural changes, enriches
the spectrum dominating the initial binding event.
4.2 Introduction
Chemical exchange, by definition, is the process by which a nucleus switches its enviornment
from one state to another, caused by an external perturbation [113]. The perturbation can be
in the form of change in pH, addition of ligand or a variation in temperature, which takes the
current state of the system (e.g. protein-ligand) to a new equilibrium state [114, 115, 116].
This change can be measured indirectly through NMR experiments by observing the structural
changes (chemical exchange) translated in terms of chemical shift perturbation and variation in
peak intensity [113]. The correlation between the binding event and the chemical exchange is
directly proportional, hence inferences based on chemical exchange gives useful insights on the
binding equilibrium itself.
The Bloch-McConnell equations explains the evolution of transverse and longitudinal mag-
netization in the presence of chemical exchange and relaxation phenomenon [117, 118, 119].
Assuming a simplified two state system, Reeves and Shaw have shown that the exchanging
components can be resolved analytically for all exchange regimes [118]. Alex et al have ex-
tended this approach for more general cases and have shown that despite the complex nature of
chemical exchange dynamics, each component can be treated as a transition and its spectrum
can be evaluated[80, 120].
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Fig. 4.1: The simulation of fast, intermediate and slow exchange titration for a two state system. A) The
simulation for fast exchange titration showing the peak walking from ppm 7.0 to 8.0, B) showing intermedi-
ate exchange regime with exceptional line broadening and C) showing slow exchange regime with intensity
variation for parent (decreasing) and daughter peak (increasing). The simulation was performed with ω1
and ω2 at 7.0 and 8.0 ppm (i.e, 3500 and 4000 Hz with B0 = 500 MHz), the linewidth (LW1/2max) at half
maximum at 25 Hz for both the states (relaxation rate = LW1/2max ∗pi Hz). The kon rate was fixed at 108 Hz
and koff rates varied as 5000, 750 and 0.01 Hz for fast, intermediate and slow exchange regimes respectively.
0.2 mM of protein concentration was titrated with ligand concentrations of 0, 0.05, 0.1, 0.2, 0.7 and 1.2 mM,
corresponding to red, orange, green, cyan, magenta and blue traces respectively. A scale factor of 100 was
multiplied to the intensities of both parent and daughter components. The simulation was carried out using
AUTOMEX, the in-house ‘c’ program written over the source code of MEXICO-3
During the course of a titration for a protein-ligand system, the occurance of chemical ex-
change is explicit in the NMR spectra. Chemical exchange is classified based on comparing its
rate ( kex = 0.5 × (kon + koff) ) with the spectrometer field strength (B0), into fast ( kex >> B0
), intermediate ( kex ≈ B0 ) and slow exchange ( kex << B0) regimes. These exchange regimes
are differentiated in the NMR spectra by their characteristic peak walking, extensive line broad-
ening and peak intensity variations for fast, intermediate and slow regimes respectively (Figure
4.1) [113, 120]. Considering a two state system (A ⇌ B), where both the components (A,
B) contribute to the final spectrum in a regime dependent manner; in both the fast and inter-
mediate cases, the individual components are summed up, resulting in a single experimental
peak. Whereas in the slow exchange case, the components remain resolved and show up as
two individual peaks (Figure 4.2) [120, 121]. Despite these differences in each type of experi-
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mental spectrum, the theory predicts the transition/individual component’s spectrum for all the
exchange regimes to be alike.
Fig. 4.2: Component spectra of a two state system for the fast, intermediate and slow exchange regimes.
(A) through (C) shows the components of parent (red) and daughter peaks (blue) for the fast exchange, (D)
to (F), for the intermediate and (G) to (I) for the slow exchange regime with the protein to ligand ratios
of 1:0.25, 1:0.5, 1:1 respectively. When the individual components are summed up, the traces depicted in
orange, green and cyan colours of Figure 4.1 would result.
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To date, many groups have sucessfully determined the NMR derived kinetic parameters
using DLNS [114, 122, 123]. In our approach, in addition to DLNS we also perform free ligand
corrections during the analysis. Additionally, the population of the free and bound states of
the protein are evaluated from the kinetic rate constants, rather than treating them as additional
optimizable parameters, which greatly reduces the number of parameters in the analysis. On
determining the kinetic and relaxation constants, we were interested in studying the relationship
between the NMR derived kinetic parameters and the actual binding process. Our analysis
suggests that the two processes, namely, the binding event and structural changes, (chemical
exchange) if they occur simultaneously, can help us derive useful conclusions on the binding
mechanism.
4.3 Results and discussion
The interaction of ligand to protein can vary from a single step binding to multiple step binding
processes and can vary in complexity from being sequential to parallel types. To perform the
line shape analysis, we have to assume the appropriate mechanism on the first hand to arrive
at the required analytical expressions. Some of the commonly encountered mechanisms are
already mentioned in chapter 3. Additionally we have considered allosteric models like:




[PL2] [model 5] (4.1)
[P ] + [L] k+1GGGGGGBF GGGGGG
k−1




[PL3] [model 6] (4.2)
In the above mechanisms, [P ], [PL](subscript) are the free and complex forms of protein re-
spectively and [L] is the free ligand concentration in solution. Upon deciding which mechanism
to use for data analysis, the Liouville, relaxation and kinetic matrices for the Bloch-McConnell
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Fig. 4.3: Calculation of local objective function. (A) and (B) are the calculated and experimental spectrums
of residues showing slow exchange characteristics. Both spectra correspond to a titration point at lower
ligand concentration. Though both parent (green) and daughter (pink) peaks are present in the calculated
spectrum, only the parent peak is visible in the experimental spectrum. So the local objective function
will be calculated based only on the parent component, omitting the daughter peak. (C) and (D) are the
calculated and experimental spectra of ligand at intermediate concentration. Here, both spectra have parent
and daughter peaks, hence both will be considered for the local objective calculation. (E) and (F) are also
calculated and experimental spectra, corresponding to higher ligand concentration. Since, only the daughter
peak is available in the experimental data, the local objective value is calculated only for that component.
The sum of all the above local objective values gives the global objective value.
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equations are set up as explained in the subsection 4.A.2. The resulting set of coupled differen-
tial equations are solved numerically to calculate the line shapes.
Fig. 4.4: The binding site of BH3I-1 and NOXA-B mapped onto the hBclXLand mMCL-1 protein. (A)
shows the two adjacent binding sites of BH3I-1 present at the hydrophobic BH3 groove of hBclXL (PDB
code: 1BXL with Bak removed), the minor and the major binding sites are highlighted with magenta and
red colours respectively. (B) Shows the mapped binding site of NOXA-B onto mMCL-1 (PDB code: 2JM6)
present at the highly conserved BH3 hydrophobic groove [124]. In both (A) and (B), the binding site residues
are shown in pink colour. All figures were made using the software Chimera [104].
4.3.1 Automation using genetic algorithm
The Bloch-McConnell equations are difficult to solve analytically, instead numerical methods
are available which are routinely adopted e.g. the matrix diagonalisation approach. The re-
sulting solutions for the Bloch-McConnell equations are the calculated spectrum which can be
compared with the experimental data to obtain the kinetic and relaxation rate constants. This
comparison can be carried out as an optimization process using the Genetic algorithm (GA)
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with an objective of minimizing the difference between calculated and experimental spectra
[90].
The details of the implementation of the optimization procedure is explained here with the
help of model 2, i.e. the two site sequential binding mechanism (equation (3.2)), where the pro-
tein exists in 3 states namely, [P ], [PL1] and [PL2]. Since the calculated spectra are obtained
by numerical approach (equation (4.24)), there are no explicit analytical expressions available
for relating the independent variable, ω (frequency) and the dependent variable, intensity, in
the spectrum. At the outset, the algorithm takes the appropriate system of equations (4.5), and
generates random values for each of the parameters namely, Larmor frequencies/offset (δA, δB ,
δC), relaxation constants(RA, RB , RC) and kinetic rate constants (k1, k−1, k2, k−2) (subsection
4.A.2, equation (4.24)). A total of ten parameters have to be optimized; futher, in the kinetic
matrix,‘K’ (equation (4.24)), the free ligand ([L]) rather than total or titrated ligand concen-
tration ([LT ]) is used in the expressions. [L] is dependent on the mechanism of interaction,
and has to be calculated from [LT ] with the given equilibrium constants KA, KB (subsection
4.A.1, equation(4.18)). Since kon, koff for equilibriums are known (i.e. the randomly generated
values), KA and KB are determined from their ratios i.e. KA = k1k−1 and KB = k2k−2 . Finally [L]
is calculated for all titrated [LT ] values using equation (4.18). After determining the elements
of the submatrices namely, [L] ,[R] and [K], they are added togeather to get the dynamic ma-
trix [D]. The dynamic matrix is diagonalised in the following step to obtain the eigenvalue
and eigen vectors, which are used to express the solution of the Bloch-McConnell equations
directly. The final solution requires a population matrix ([M0]),whose elements are constituted
by the mole-fraction/concentration of the exchanging species at equilibrium, which inturn is
dependent on the amount of ligand [LT ] added at each titration step. Using [L] and Keq con-
stants, mole-fractions of [P ], [PL1] and [PL2] for each [LT ] are evaluated (subsection 4.A.1,
equation(4.12)). From the eigenvalues, eigenvectors and [M0], the line shapes of individually
exchanging components are written explicitly (equations(4.9) - (4.10)). For a three state mech-
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Fig. 4.5: Line shape analysis for binding site residues of hBclXL (A), (C), (E), (G) shows the single site model
fitting for binding site residues G94, F146, G148, G196 respectively. (B), (D), (F), (H) shows the two site
model fitting for the respective residues in the above mentioned order. The spectra show a color gradient
from red to black with concomitant increases in P:L ratios of 1:0, 1:0.23, 1:0.46, 1:0.69, 1:0.92, 1:1.14, 1:1.38,
1:1.61, 1:1.82, 1:2.07, 1:2.30.
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anism, we can expect three calculated line shapes corresponding to exchanging components at
each [LT ] value, but the experimental spectrum has its components summed up for fast and in-
termediate exchange systems, so the calculated individual components also need to be summed
up before comparing with the experimental data.
Fig. 4.6: 15N HSQC spectrums of F146, G198, G94 and G196 residues of hBclXL , when titrated with BH3I-1
(A) to (C) are the contour plots of selected residues present at the binding site of hBclXL , when titrated with
BH3I-1 . All the residues show characteristic peak walking, typically seen for fast exchange regimes. The
contours red, green, orange, yellow, coral, cyan, cyan, magenta, pink, violet represents the protein to ligand
ratios of 1:0, 1:0.23, 1:0.46, 1:0.69, 1:0.92, 1:1.14, 1:1.38, 1:1.61, 1:1.82, 1:2.07, 1:2.30 respectively. All figures
were made using the software gnuplot 4.4 [108].
The comparison is done in terms of the sum of the squared difference between the calculated
and experimental spectrums of individual components, which is termed as the ‘local objective
value’ (LO) (figure 4.3). For example in the slow exchange case for the mechanism 2, since the
components [P ] and [PL2] are seen experimentally its calculated spectra are compared with
their respective experimental spectrum as shown in the equation (4.3) (figure 4.3). However, the
intermediate state [PL1], which is invisible in the experimental data, would be excluded from
the calculations. The local objective value is evaluated for each titration point and added up to
give the global objective value (GO)(equation (4.4)). The overall objective of the optimization
is to minimize the difference between the calculated spectrum and the experimental spectrum
i.e, to acheive the minimum value for the global objective function (GO). The algorithm will
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randomly generate sets of possible solution values based on the population number. For each
member of the population (individual), the GO will be evaluated. The individuals with lower
GO values are considered as better solutions and are retained and allowed to move on to the
next step of the process. This selection of the best solution is similar to what is seen in na-
ture, the ‘natural selection’. After selection, mathematical operators analogous to crossing over
and mutation are performed on individuals offering variability in the solution set and also pre-
venting the optimization from being trapped in to the local minimum solutions. The resulting
solution sets (the offsprings) are allowed to go the next round of selection process, just like its
predecesors (the parents). This process will be repeated several times based on the ‘generation
number’, till a consistently minimized converged value results for the GO function. In our au-
tomation program, AUTOMEX, the implementation has been made for the models considered
in the section 4.3. Furthermore, the source code of the program is available for customizing
mechanisms (Section 4.A.3).

























4.3.2 Analysis of fast exchange titration (hBclXL and BH3I-1 )
hBclXL (human) is a key member of the Bcl2 family of proteins, which is involved in many
of the regulatory functions of the apoptotic pathway [46]. In normal cells hBclXL prevents
apoptosis, by inhibiting pro-apoptotic proteins like bax, bak etc., belonging to the same Bcl2
family [46, 50]. Over expression of hBclXL has been reported in different cancer conditions like
AML (Acute myeloid leukemia), multiple myeloma and breast cancer [125, 126]. Undesirably,
its upregulation confers resistance upon cancer cells to treatment with chemotherapeutic agents
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like doxorubicin and cisplatin[125]. Hence, hBclXL is considered one of the primary targets for
drug development in cancer research [127]. Recently, a small molecule named BH3I-1 , has
shown promising results in inhibiting ‘over expressed’ hBclXL by displacing its natural binding
partner, the pro-apoptotic Bax protein[94, 128]. The affinity (Kd) of BH3I-1 to hBclXL is found
to be 7.813 µ M as determined by fluorescence polarisation displacement assay[129]. Similar
results were determined through our NMR based chemical shift analysis (Kd: 33.3 µ M), with
further identification of two adjacent binding pockets for BH3I-1 (Figure 4.4(A))[115].
Using the same NMR titration data, we performed the dynamic line shape analysis (DLNS),
using our program AUTOMEX (Automated MEXICO based line shape analysis program). We
selected some of the binding site residues like G94, F146, G148 and G196, and some of the
non binding site residues like Q19, T172 ( Figure 4.6), for lineshape analysis to fit different
binding models like single and double site binding modes. Both categories of residues fit best
to the two site model, with a relatively better non reduced χ2 value. (The non reduced χ2
value differs from the reduced χ2 value by not considering the number of data points and the
number of optimized parameters during the fitting procedure.) The lower the chi-square value
the better the model explains the experimental data. Our results suggests the two-site model to
be better than the single site model, hence the double site model is used for our further analysis
(Figure 4.5, 4.7). Additionally statistical methods like the F-test and Akaike’s criteria are also
used to justify the model selection. Through previous chemical shift based analysis, most of the
perturbed residues were found to conform well to a single site model, whereas the same residues
entailed the two site model for their dynamic line shape analysis[115]. This contrast is due to
the fact that, chemical shift analysis uses only the chemical shift values from the spectrum,
whereas DLNS makes use of all the available information like linewidth, phase, intensity and
chemical shift of the peaks. All four of these different, non redundant informations on the same
binding process help us to elucidate the mechanism accurately. Also from the chemical shift
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Fig. 4.7: Line shape analysis for non binding site residues of hBclXL (A), (C) shows the single site model
fitting for non binding site residues Q19, T172 respectively. (B), (D) shows the two site model fitting for the
respective residues in the above mentioned order. The spectra show a color gradient from red to black with
concomitant increase in P:L ratios of 1:0, 1:0.23, 1:0.46, 1:0.69, 1:0.92, 1:1.14, 1:1.38, 1:1.61, 1:1.82, 1:2.07,
1:2.30.
based analysis, we identified two adjacent binding sites that are 10 A˚ away from each other,
which DLNS also corroborates to be correct by fitting best to the two site binding mechanism.
A comparison of the NMR derived Keq value (3.38 × 103 to 7.479 × 104) with the ITC
results (9.32 × 104 to 48.7 × 104) differed quantitatively by an order of 3 to 6, which seemed
consistent with the chemical shift based analysis (2.06 × 103 to 24.11 × 104). The Keq does not
vary significantly among the binding and non binding site residues, whereas the koff values
differed by an order of 101 to 103 for the binding site residues in comparison with non binding
site residues. The value of koff is a good measure of the ligand’s residence time at the binding
pocket, i.e, the larger the koff value, the shorter the time spent by the ligand in the complexed
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form [PL]. Hence, the determined koff value can be used as a good criteria to distinguish the
binding site residues from the rest of the residues.
Another interesting pattern observed between binding and non binding site residues is the
difference in population variation as the titration progresses (Figure 4.13). F146 and G148,
the binding site residues differed drastically from Q19 and T172, the non binding site residues,
by reaching half saturation (fA = 0.5 at LT = 0.266 mM) much quicker than the non binding
site residues (> 0.660 mM). Further, the saturation for non binding site residues could not be
reached even at the maximum titrated ligand concentration (LT = 1.330 mM). The rate at which
a residue reaches its half saturation is infact a measure of the affinity of the ligand towards
the residue of interest. Similar to our previous observation with chemical shift based analysis,
the initial rate of perturbation (a sensitive criteria to distinguish the binding site residues from
the bulk residues), the analogous rate of change within a population in DLNS can be used to
identify the binding site residues. Infact, both the rate of change of perturbation and the rate
of change of population are proportional to each other (δ ∝ fA) in the fast exchange regime.
Hence, either of these can be used for identifying the binding site residues.
4.3.3 Analysis of slow exchange titration (mMCL-1 and NOXA-B )
Like BclXL, MCL-1 is also a prosurvival BCL-2 protein, which plays major physiological roles
in B and T cell lymphopoiesis and in early haematopoiesis by regulating apoptosis for T and B
cells [125, 130]. Over expression of MCL-1 has been reported in myeloma cells, AML, ovarian
cancer and cervical cancer cells [131]. MCL-1 is selectively inhibited by a pro-apoptotic protein
called NOXA , which keeps its pro-survival activity in check. NOXA binds to the classical BH3
hydrophobic groove of MCL-1 , spanned by the highly conserved BH1, BH2 and BH3 domains
[52, 124, 132]. The binding interaction of NOXA onto MCL-1 has been well charactersied
using NMR, SPR and FP assays (Figure 4.4(B)) [124, 133]. We designed a minimal peptide
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Table 4.1: The parameters obtained by line shape analysis for binding and non-binding site residues of
hBclXL and BH3I-1 system (fast exchange regime) The fitting results for selected binding and non binding
site residues, using double and single site models, are listed below. The offset (δ ppm), relaxation rate (as
linewidth (LW ) at half maximum in ppm; R2 = pi ∗ LW ∗ B0 Hz), kinetic rates (kon and koff ) and the
corresponding equilibrium constants (K) are optimized using apropriate models till a convergent χ2 value
is acheived.
Residue δ Line width Exchange Kequilibrium χ2 Model
no (ppm) (Hz) rate (Hz) no
Binding site residues
G94 δ0 ∶ 9.124 LW (1) ∶ 83.291 Kon(1) ∶ 1.963 × 109 K1 ∶ 3.388 × 103 8.22 2
δ1 ∶ 8.978 LW (2) ∶ 419.597 Koff(1) ∶ 5.794 × 105 K2 ∶ 1.699 × 104 (128.96) (1)
δ2 ∶ 8.923 LW (3) ∶ 77.005 Kon(2) ∶ 3.915 × 109
Koff(2) ∶ 2.304 × 105
F146 δ0 ∶ 9.198 LW (1) ∶ 81.719 Kon(1) ∶ 6.136 × 1010 K1 ∶ 5.922 × 104 14.75 2
δ1 ∶ 9.378 LW (2) ∶ 182.297 Koff(1) ∶ 1.036 × 106 K2 ∶ 2.708 × 104 (489.69) (1)
δ2 ∶ 9.377 LW (3) ∶ 91.148 Kon(2) ∶ 2.836 × 109
Koff(2) ∶ 1.047 × 105
G148 δ0 ∶ 8.953 LW (1) ∶ 83.291 Kon(1) ∶ 1.776 × 1010 K1 ∶ 8.168 × 103 10.75 2
δ1 ∶ 9.084 LW (2) ∶ 320.591 Koff(1) ∶ 2.174 × 106 K2 ∶ 7.479 × 104 (304.78) (1)
δ2 ∶ 9.155 LW (3) ∶ 102.149 Kon(2) ∶ 6.938 × 107
Koff(2) ∶ 9.270 × 102
Non binding site residues
Q19 δ0 ∶ 7.691 LW (1) ∶ 72.285 Kon(1) ∶ 5.199 × 1010 K1 ∶ 1.423 × 102 1.41 2
δ1 ∶ 8.128 LW (2) ∶ 136.714 Koff(1) ∶ 3.654 × 108 K2 ∶ 3.834 × 104 (5.39) (1)
δ2 ∶ 7.755 LW (3) ∶ 84.857 Kon(2) ∶ 1.142 × 1011
Koff(2) ∶ 2.980 × 106
T172 δ0 ∶ 8.637 LW (1) ∶ 73.857 Kon(1) ∶ 6.578 × 109 K1 ∶ 1.065 × 102 2.75 2
δ1 ∶ 9.683 LW (2) ∶ 15.714 Koff(1) ∶ 6.177 × 107 K2 ∶ 2.256 × 103 (3.61) (1)
δ2 ∶ 8.458 LW (3) ∶ 138.285 Kon(2) ∶ 1.839 × 1011
Koff(2) ∶ 8.152 × 107
of 20 amino acid length from the sequence of NOXA protein, containing the BH3 domain
‘B’ which shows high sequence similarity to hNOXA-B (Figure 4.8) [134]. An NMR titration
was carried out with increasing concentration of NOXA-B into mMCL-1 (0.22 mM) with the
protein to peptide ratios of 1:0, 1:0.09, 1:0.18, 1:0.46, 1:0.73, 1:91, 1:1.82, and 1:2.73. The
spectra showed a typical slow exchange regime, which is consistent with the expected affinity
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of NOXA-B in nM (Kd = 24 nM) to mMCL-1 . The line shape analysis was carried out for
some of the selected binding site residues like H205, E205, V246 and F251, and non binding
site residues like A190 and V280, which are > 10 A˚ away from the BH3 binding groove. The
model fitting asserts the stoichiometry of NOXA-B to mMCL-1 to be 1:1, i.e, a single site
binding mechanism. The determined Keq values for both binding and non binding site residues
are almost identical and lie within the range of 0.224 to 6.098 ×104. This value differs by an












Fig. 4.8: The sequence alignment of mNOXA (mouse) with hNOXA (human) sequence. The hNOXA se-
quence has only one BH3 domain, whereas mNOXA has two domains namely A (blue), B (red). The se-
quence of the NOXA-B peptide designed for mMCL-1 + NOXA-B titration is underlined and highlighted in
yellow color.
Theoretically, when kon is increased, the Kequilibrium constant also increases as Kequilibrium =
kon
koff
, and expectedly, the area of the parent or daughter peak will vary rapidly i.e, decrease or
increase respectively. But simulation results showed that after a certain threshold value for
kon, any further increase virtually has no effect on the areas of peaks/population in the slow
exchange regime ( Figure 4.12). This is due to the fact that the kon value may become insensitive
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over a threshold level because, in line shape analysis the pseudo rate constant (kon[L]) is used
rather than kon itself. In the tight binding slow exchange regime the free ligand [L], is almost
negligible or zero, until the binding sites are saturated. Inspite of the value the kon rate constant
can take, the pseudo rate constant will be zero as [L] = 0 (Figure 4.13).
Fig. 4.9: 15N HSQC spectrums of residues H205 and I245 of mMCL-1 , when titrated with NOXA-B (A) to
(C) shows the titration spectra of H205, exhibiting the typical slow exchange pattern. The parent peak 205(a)
(red contour) intensity decreases as the daughter peak (blue contours) increases as titration progresses. The
protein to ligand concentrations in (A), (B), (C) are 1:0, 1:1.82, 1:2.73 respectively. Similar results for residue
I245 are shown in (D), (E), (F), with the protein to ligand ratios of 1:0,1:0.91,1:1.82 respectively. The grey
contours in (D) represents a stray peak adjacent to I245, that is neither related to I245(a) or I245(b).
The threshold value of kon is related to the inverse of the concentration of ligand used in
the titration. For example, the ligand titration carried out in 0.01 to 10 mM range, resulted in
threshold of kon to be around 1000 sec−1. This threshold value has resembelance to the criteria
‘C’ routinely used in ITC experiments to assess the concentration of protein while designing
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the experiments. ‘C’ is defined as nPT
KD
, where n, is the binding stoichiometry; to measure KA
accurately, ‘C’ value should be within the range of 1 to 1000 [135, 136].
To verify whether the insensitivity of kon is the reason for low KA value, we took already
optimized parameters of fitted residues, and increased the value of kon alone, keeping other
parameters constant. We supposed that the area should not vary if the optimized kon value rep-
resented the threshold value. But we observed significant variation in peak areas, suggesting
that the obtained kon and koff are not the misrepresented values of the actual binding equilib-
rium, rather, they represent a different process, which we speculate to be an equilibrium of the
structural changes. Despite the discrepancy in Keq value, it is interesting to note that the bind-
ing and the non binding site residues showed a similar population variation profile along the
course of titration. In a tight binding slow exchange regime like NOXA-B and mMCL-1 , the
structural rearrangement caused by the binding event could be global, resulting in distinct free
and bound forms, thereby affecting all residues. In such a case, despite whether the residue is
present at the binding or non-binding site, the profile of population variation would be similar.
This is markedly different from the population profile seen for the fast exchange regime, where
binding and non binding site residues exhibit different rates in reaching saturation.
4.3.4 Mechanism of interaction of mMCL-1 and NOXA-B
The NMR derived parameters suggest a very low equilibrium constant compared to the fluores-
cence (FPA) and biocore (SPR) analysis. From the results of kon based simulation performed
for optimally fitted residues, we ruled out the insensitivity of kon to be the reason for the low
Keq value. We speculate that this discrepancy can be explained by considering the interaction
process being constituted by a faster binding event preceeding the rate limiting structural rear-
rangement. This is analogous to the well known ‘induced fit mechanism’ commonly seen in
enzyme-substrate binding mechanics ([P ] + [L] k1GGGGGA [PL∗] k2GGGGGBF GGGGG
k−2
[PL] ). The initial binding
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Fig. 4.10: Line shape analysis for binding site residues of mMCL-1 (A) and (B) shows the spectra of parent
and the daughter peaks of H205, appearing at two different ‘N’ resonances as indicated. Similarly, (C,D),
(E,F), (G,H) are the slow exchange spectra for A208, V246 and F251 residues respectively. The spectra show
a color gradient from red to black with concomitant increase in P:L ratios of 1:0, 1:0.09, 1:0.182, 1:0.455,
1:0.727, 1:0.909, 1: 1.818, 1:2.727.
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Fig. 4.11: Line shape analysis for non binding site residues of mMCL-1 (A) and (B) shows the spectra of
parent and the daughter peaks of A190. Similarly, (C,D) are the spectra of residue V280. The color gradient
in the spectra from red to black indicates the concomitant increase in P:L ratios of 1:0, 1:0.09, 1:0.182,
1:0.455, 1:0.727, 1:0.909, 1: 1.818, 1:2.727.
process triggers or induces a structural change in both the protein and the ligand molecules.
NMR being a time averaged technique depicts both the contribution of the binding event and
its subsequent structural rearrangement in the same spectrum. Since the binding event would
be faster, and modulated by diffusion constrained kon and a very low koff value, the rate limit-
ing step would be the slow structural rearrangement process. Hence, what we measure as Keq
through NMR, infact represents the equilibrium of the structural changes rather than the binding
event itself. This unsynchronization between the binding and structural change account for the
low Keq value observed in our analysis.
In addition, we also consider the fact that NMR is a less sensitive technique in terms of
the concentration of analyte required for effective physical measurement (10−3 to 10−6 M),
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Fig. 4.12: Simulation of free ligand concentration and population for different kon values. (A) shows the
profile of how free ligand concentration varies with the total titrated ligand concentration, for a simulation
of weak binding protein-ligand titration with kon = 100 Hz. A modest curvi-linear pattern is observed. The
pattern becomes more linear and diagonal, when kon << 100, i.e, 10 Hz, at this condition [Lfree] = [Ltotal].
(B) shows the variation of free (blue trace) and bound form (red trace) of protein in mole-fraction, for the
simulated titration carried out with 0.22 mM of protein and ligand concentrations ranging from 0 to 0.5 mM.
(C) and (D) are similar to (A) and (B) except that the simulation was carried out with kon = 1000 Hz. In
this case, the inverse of kon, i.e, 11000 Hz, is comparable to the magnitude of the titrated ligand concentration(10−3 M). Unlike (A), the non-linear relationship between [Lfree] and [Ltotal] becomes more pronounced
in (C). When compared for the [L] required to acheive half saturation (i.e, f[P ] = f[PL] = 0.5) for (B) and
(D), (D) required 0.1 mM, whereas (B) required > 0.2mM. This is a striking distinguishing feature of strong
binding ligands from the weakly interacting ones. (E) and (F) are simulation profiles of a strong binding
case, where [Lfree] remains negligible (≈ 0), until the binding sites are completely saturated (≈ 0.22 mM). As[Lfree] = 0, the pseudo rate constant, kon[Lfree] would also become negligible (≈ 0), despite the value kon
can take. This explains the insensitivity of kon over a threshold value, which is related to the concentration
of ligand used in the simulation. The problem of kon insensitivity can be averted if the same experiment is
performed with ligand concentration comparable in magnitude to kon value. (G) and (H) shows the titration
simulated at 0.22 µ M of protein and ligand ranging from 0 to 0.50 µ M for kon = 106 Hz. The pattern of[Lfree] and the population reverts back to the normal pattern seen in (C) and (D). Unfortunately, NMR
experiments requires analyte (protein) concentration in mM range rather than in µM range, which makes
the realization of this simulation practically infeasible.
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compared to other techniques like SPR, ITC and FPA techniques (10−6 to 10−9 M). In global
measurement techniques like ITC, FPA, SPR theKeq are measured through kinetic (Keq = KonKoff )
or thermodynamic (∆G = −RT logKeq) approach. Despite the differences in approach, these
techniques are primarily concerned with quantifying the binding event rather than the structural
changes it causes. For example, in ITC, the heat released is proportional to the binding of
ligand and the displacement of ordered solvent molecules at the binding site. In FPA, the ability
of competitive ligand to displace an already bound ligand is measured. In SPR, again the ability
of the ligand to associate and dissociate from the immobilized protein is directly measured.
In principle, NMR differs from these above techniques by measuring the perturbation of the
nuclear environment, which directly reflects the structural change rather than the binding event,
hence, the calculated Keq also represents the structural changes.
4.3.5 Comparison of optimized parameters of fast and slow exchange regimes
It is clear from the analysis of the fast exchange regime that the binding and non-binding site
residues can be distinguished from the model fitted parameters, particularly for the koff rate
constant, variation within the population profile, and to some extent the difference in line width
between free and the bound forms (∆LW ). For hBclXL + BH3I-1 , the structural changes are
localized to the binding site and its adjacent residues, hence the distinction between binding
and non binding site residues is fairly straight forward. On the other hand, when the bind-
ing induced structural rearrangement becomes global, affecting all the residues as seen with
mMCL-1 + NOXA-B , the model fitted parameters may not be able to differentiate the binding
site residues from the bulk of residues. The slow exchange system (mMCL-1 + NOXA-B )
shows such a pattern for both binding and non-binding site residues with similar koff values
ranging from 10−2 to 10 and also the population variation profile is similar. Other than the ki-
netic rate constant, the DLNS also yields an apparent R2 relaxation rate constant, which has
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Table 4.2: The parameters obtained by line shape analysis for binding and non-binding site residues of
mMCL-1 and NOXA-B system (slow exchange regime) The single site binding model was used for all the
analysed residues, the resulted optimized parameters are offset (ppm), relaxation rates (as linewidth (LW )
at half maximum in ppm; R2 = pi ∗LW ∗B0 Hz) and kinetic rates (Hz).
Residue δ Line width Exchange Kequilibrium χ2 Model
no (ppm) (Hz) rate (Hz) no
Binding site residues
H205 δ0 ∶ 7.552 LW (1) ∶ 78.576 kon ∶ 3.165 × 104 K ∶ 10.989 × 103 8.593 1
δ1 ∶ 7.447 LW (2) ∶ 88.005 koff ∶ 2.880 × 100
E206 δ0 ∶ 6.907 LW (1) ∶ 50.289 kon ∶ 6.320 × 103 K ∶ 6.313 × 103 24.513 1
δ1 ∶ 6.751 LW (2) ∶ 69.147 koff ∶ 1.001 × 100
V246 δ0 ∶ 9.040 LW (1) ∶ 89.577 kon ∶ 6.098 × 104 K ∶ 8.422 × 103 24.524 1
δ1 ∶ 9.668 LW (2) ∶ 66.004 koff ∶ 7.240 × 100
F251 δ0 ∶ 8.690 LW (1) ∶ 72.290 kon ∶ 1.200 × 103 K ∶ 5.359 × 103 23.001 1
δ1 ∶ 8.838 LW (2) ∶ 86.434 koff ∶ 2.240 × 10−1
Non binding site residues
A190 δ0 ∶ 8.856 LW (1) ∶ 64.433 kon ∶ 1.111 × 104 K ∶ 1.111 × 103 5.327 1
δ1 ∶ 8.601 LW (2) ∶ 91.148 koff ∶ 1.000 × 100
V280 δ0 ∶ 8.821 LW (1) ∶ 58.146 kon ∶ 9.302 × 103 K ∶ 9.302 × 103 5.668 1
δ1 ∶ 8.777 LW (2) ∶ 81.719 koff ∶ 1.000 × 100
its contribution from different relaxation mechanisms like, Rex (chemical exchange induced
relaxation), inhomogeneity of the magnetic field, molecular tumbling, internal correlation, etc.
Using this R2 value to interpret the interaction mechanism would be misleading, hence addi-
tional experiments like T1, T2, steady state NOE and relaxation dispersion are required for the
proper analysis. By comparing both regimes, we conclude that when the rate of binding process
is comparable to the rate of structural changes (e.g, fast exchange), accurate determination of
Keq is possible. On the other hand, if the two events occurs in an unsynchronized manner with
the binding event preceeding the rate limiting structural changes, (as seen with slow exchange
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case) the determined equilibrium constant represents the induced structural changes rather than
the equilibrium of the binding event.
Fig. 4.13: Population variation with progression in titration (A) The variation of population of binding site
residues (#: F146, ∗: G148) and non binding site residues (#: Q19, ∗: T172) of the fast exchange system
(hBclXL + BH3I-1). (B) The variation of population of binding site residues (# : H205, ∗: V246) and
non binding site residues (#: A190, ∗: V280) of slow exchange system (mMCL-1 + NOXA-B ). In
the fast exchange regime, the population profile of binding and non binding residues can be clearly
distinguished, whereas for slow exchange, the distinction is not apparent.
4.4 Concluding remarks
Adopting the transition probability approach for dynamic line shape analysis, we were able
to automate the analysis of 15N HSQC titration data belonging to different exchange regimes.
Inclusion of a mechanism dependent [L] correction and population evalaution during optimiza-
tion has enabled us to perform accurate analysis with a reduced number of optimized parame-
ters. The results from analyzing a fast and a slow exchange system shows that in general there
is a regime dependent limitation while using the kinetic parameters to interpret the binding
process. For the fast exchange regime, the binding event and structural changes occur simul-
taneously. Hence the NMR determined equilibrium constants are consistent with parameters
obtained through other techniques. While for the slow exchange regime, the rate limiting struc-
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tural changes dominate the spectrum. Hence, the NMR determined equilibrium constant for
slow exchange differs by many orders from the actual binding equilibrium constant measured
through other techniques. Despite this regime dependent limitation on the accuracy of the Keq
value, the mechanism of interaction can be accurately delineated through dynamic line shape
analysis.
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4.A Appendix: Theory
We start with a set of modified Bloch-McConnell equations, considering a general system con-
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where M ′A represents the differential of MA(t), the transverse magntization of component A,
and δA , RA, the offset and transverse relaxation rates of A respectively. The other exchanging
components are represented in subscript as B,C,⋯,N .
The elements of the kinetic matrices i.e, from k11 through knn, depends on the type of
interaction/binding mechanism (e.g, single site, or multiple sites interaction) (section 4.A.2).
Summing up the Liouville (L), relaxation (R) and kinetic (K) matrices in the R.H.S, we get the
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The solution to the above, coupled differential equations, can be written by diagonalisingD and
















































In equation 4.7, a1,⋯, nn are the elements of eigenvectors and a′1,⋯, n′n are the elements of
inverse of eigenvectors. The diagonal elements of the matrix E are the eigenvalues of D. The
elements of the M0 matrix are the population of exchanging species at equilibrium condition.
From the elements of E, U and U−1, the time domain signal for the component ‘A’ can be
written as [120, 137],
MA(t) = (a1 + b1 + c1 + . . . + n1)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
sum of U’s column vector
(a′
1
∗MA0 + a′2 ∗MB0 + a′3 ∗MC0 + . . . + a′n ∗MN0)´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
sum of the product of row elements of U−1 with column elements of M0
e−λ1t (4.8)
= (Aprefactor)e−λ1t (4.9)
In equation(4.8), the factors multiplying the exponetial term is abstracted as Aprefactor. As both
the elements of eigenvalue and eigenvectors are complex in nature (i.e, of the form x + iy), the
Aprefactor and λ1 are also inherently complex. Fourier transformation of the time domain signal







iω − λ1 (4.10)
The four basic characteristics of a peak namely, the intensity, phase, offset and linewidth can
be quantitatively expressed with the help of equation (4.10) [137, 120]. Since Aprefactor and λ1
are complex numbers, if we express them as (a + ib) and (c + id), then the intensity is given
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by the magnitude
√
a2 + b2, the phase by θ = tan−1 ( b
a
), the offset by d and the linewidth at
half maximum by c. Further, since the terms a, b, c, d are constituted by k, R and λ, hence
the above expression quantitatively explains how the Liouville terms, kinetic and relaxation
rates modulates different characteristics of an NMR peak. The component signal for the other
exchanging species are calculated in the same way as carried out for ‘A’.
4.A.1 Appendix:Mechanisms based ligand correction and calculation of
population
During the titration experiment, the amount of ligand added represents the total ligand con-
centration [LT ]. The LT may exist in different state of complexation, varying from free form
[L], to bound forms like [PL], [PL1], [PL2] etc. The number of bound forms is depen-
dent on the mechanism of interaction, for example, in model 2 (Equation (3.2)), the [LT ] =
[L] + [PL] + [PL1]. By simple arithmatic, we can show that [L] can be obtained by solving
mechanism dependent polynomial equation, and choosing the best root that is close to LT . The
following polynomial equations are derived as explained in [115], for the mechanisms men-
tioned in section 4.3.
KA[L]
2 + (1 + [PT ]KA −KA[LT ])[L] − [LT ] = 0 [model 1] (4.11)
KAKB[L]
3 + (KA + [PT ]KAKB − [LT ]KAKB)[L]
2
+ (1 + [PT ]KA − [LT ]KA)[L] − [LT ] = 0 [model 2] (4.12)
KAKBKC[L]
4 + (KAKB + [PT ]KAKBKC − [LT ]KAKBKC)[L]
3
+ (KA + [PT ]KAKB − [LT ]KAKB)[L]
2 + (1 + [PT ]KA − [LT ]KA)[L] − [LT ] = 0 [model 3] (4.13)
K1[L]
n+1 + ([PT ]K1 − [LT ]K1)[L]
n + [L] − [LT ] = 0 [model 4] (4.14)
(1 +KB)KA[L]
2 + (1 + [PT ]KA(1 +KB) − [LT ]KA(1 +KB)[L] − [LT ] = 0 [model 5] (4.15)
(1 +KC)KAKB[L]
3 + (KA + [PT ]KAKB(1 +KC) − [LT ]KAKB(1 +KC))[L]
2
+ (1 + [PT ]KA − [LT ]KA)[L] − [LT ] = 0 [model 6] (4.16)
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Where KA, KB , etc. represents the equilibrium constants for the corresponding equilibrium
steps and PT , the total protein concentration. ‘n’ in model 4, represents the stoichiometry of
ligand to protein, i.e n = 1, 2 or 3 etc. Assuming equilibrium condition, from the calculated [L],
we can get the population or mole-fraction for individual species/components at each titration
points. The following equations are used for the calculation of population, which in turn forms
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KA[L]



































1 +KA[L] +KAKB[L]2 +KAKBKC[L]2
, f[PL1]6 =
KA[L]












CHAPTER 4. Analysing all chemical exchange systems Appendix: Theory
4.A.2 Appendix:Mechanism dependent setting up of Liouville, relaxation
and kinetic matrix
Based on Bloch-McConnell formulation, the set of coupled differential equations for chemically
exchanging species (i.e, A, B, C etc.) can be written as shown below. The L, R and K matrices
on the R.H.S are mechanism dependent and the summed up R +K matrix is called as dynamic
matrix. Notably, the K matrix requires [L] rather than [LT ], which is determined as explained
in previous section 4.A.1. The detailed derivation of these equations can be referred to [120,















































































































































































































































































































iδA 0 0 0
0 iδB 0 0
0 0 iδC 0






























RA 0 0 0
0 RB 0 0
0 0 RC 0






























−k1[L] k−1 0 0
k1[L] −(k−1 + k2[L]) k−2 0
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4.A.3 Appendix:Data preperation for line shape analysis
AUTOMEX requires the Fourier transformed (FT) data and the assignment files for each titra-
tion point. Using NMRpipe, the 2D FID can be processed , phase corrected and saved as
FT data [64]. The peaks in each of the titration data are assigned with SPARKY and the list
files are saved [140]; AUTOMEX (Automated MEXICO based program, [88]), reads the as-
signment files sequentially starting from first to last titration, extracts the peaks from the FT
data and fits them to the ‘phased Lorentzian model’. The resulting fitted model is used as an
exact replica for experimental data in DLNS analysis. The source code and the binaries of




Conclusion and future direction
Binding site analysis has been the major focus of this entire work, with more emphasis on the
dynamical parameter, the chemical exchange in relevance to NMR chemical shift perturbation
experiments. Some of the insights obtained on studying fast as well as slow exchange systems
are summarized as follows:
1. It is well known that chemical exchange and relaxation are highly influenced by ligand
interactions with protein. Here we have analysed fast chemical exchange regimes con-
sidering different kinetic mechanisms and found that:
(a) The initial rate of change of chemical shift perturbation with respect to the titrated
ligand concentration is a critical parameter to differentiate binding site residues from
the non binding site residues.
(b) For highly dynamic protein-ligand systems involving rapid and drastic structural
changes, there is a possibility that the analysis could go wrong. Even with such
cases, the initial interaction sites of ligand to protein can be mapped through the ini-
tial rate of change of population. However, the binding site analysis for such cases,
has to be carried out with the perturbation rates calculated at ligand concentrations
slightly over the half saturation limit.
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(c) NMR measurements represents the events happening at local environment much
more accurately than the events affecting the system globally. For a two ligands
system interacting with a protein molecule, if the two interaction sites are far away
from each other (> 10A˚), the residues at the interface (inbetween the two sites)
would behave well for a two site binding model, whereas, the residues at the binding
sites would be best represented with single site model.
2. The rate of change of perturbation is infact the analogous representation of the rate of
change of population. In fast exchange regime either of it can be used to distinguish the
binding site residues. Whereas the same criteria was not much useful in mapping the
binding sites for a slow exchange regime that involved global structural changes.
3. Dynamic line shape analysis for a slow exchange regime reveals that the faster binding
event is not synchronised with the much slower structural changes or chemical exchange
event. In such cases, the determined binding equilibrium constants actually represents
the equilibrium of rate limiting structural changes.
4. The automated analysis for fast exchange systems using chemical shift perturbation and
the dynamic line shape analysis for all exchange regimes, has been implemented through
optimization techniques, considering accurate corrections for free ligand concentration
and population calculations.
There are two interesting directions that can be taken to improve the current analysis.
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5.1 Quantum mechanical approach to study protein-ligand
interactions
The conclusions of this thesis were based on parameters obtained through classical approach.
The same problem can be approached in a quantum mechanical way. The theories for different
chemical exchange scenarios such as mutual and non-mutual exchange cases, have been dealt
with in detail as early as the 1960’s[141, 142]. In quantum mechanical approach, the elements
of the density matrix, also called as coherences, gives deeper insights into the binding process to
differentiate the individual contributions like hydrophobic, ionic or solvent exchange, etc. This
approach would pave a way to demark the actual binding processes from the allosteric structural
changes accurately.
5.2 In-silico drug design
In silico drug design can be carried out for those mapped binding sites using currently avail-
able softwares like “Ligbuilder”[143]. An example molecule built for the binding site of
hBclXL using “Ligbuilder” is shown in figure. 5.1.
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Fig. 5.1: In-silico drug designed for BH3 groove of hBclXLusing ‘Ligbuilder’
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